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GENERAL INTRODUCTION 
Cytologie examination of lung sputum has been known for many 
years as the least uncomfortable method to obtain a diagnosis in 
patients suspicious for lung cancer. 
The microscopic examination of sputum in diagnosing lung 
malignancy was first described by Hampeln in 1 7І, and 
originated from the examination of sputum in patients suspicious 
for lung tuberculosis. 
In The Netherlands the first report of sputum diagnosis of 
lung cancer was published by Josselin-de Jong in 19182. Sputum 
was embedded in paraffin and prepared for histological 
examination. 
The cytologic examination of sputum was introduced by 
Dudgeon and Wrigley in 1935'. "Direct" smears were prepared from 
suspicious looking parts of fresh sputum specimens. This 
procedure may result in sampling errors, because only part of the 
specimen is investigated microscopically. The introduction of a 
blender in the processing of sputum was described by Saccomanno 
in 1963*. By blending the sputum at high speed the mucus in it is 
homogenized, which allows centrifuging of the specimen. From the 
sediment smears with high cell concentration can be prepared 
without the risk of sampling errors as with direct smears. 
Periodically other techniques for freeing and concentrating 
tumor cells by mucolysis are reported in the literature, but 
these rather laborious and time consuming procedures are not very 
practical and as a rule survive for only short periods of time5. 
An examination of the literature to compare the above 
mentioned three main methods of sputum processing reveals the 
following results. For the direct "pick and smear" method several 
studies on the sensitivity and specificity of this method for 
sputum cytology exist. The majority however deal exclusively with 
patients with primary lung cancer. 
In the study of Van der Slikken sputum was examined in 140 
patients with primary lung cancer. In 70.7 % a correct positive 
3 
diagnosis was obtained. In two patients a false positive 
diagnosis was made. 
Oswald? reported about 2,035 patients with primary lung 
cancer and found a correct positive rate of sputum cytology of 
595Ó and a false positive rate of 0.7%. When three sputum samples 
were examined the correct positive rate rose to 69$, and with 
four sputum samples to 85%. 
JohnstonS studied 363 patients with lung malignancies, 320 with 
primary lung cancer and 43 with metastatic lung tumors. Sputum 
cytology achieved a correct positive rate of 47S and β false 
positive rate of 2%. 
Payne' analyzed sputum results in 656 patients with primary 
lung cancer and found a correct positive rate of 42Й when one to 
eight sputum samples were examined. No specificity rates were 
given. 
Diagnostic accuracy of paraffin embedded sputum cytology was 
studied by three authors: LankesterlO, Goossenll and WachalZ. 
Lankester studied 25Θ patients with histologically proven primary 
lung cancer and 9 patients with metastatic lung malignancies. He 
achieved a sensitivity of 72.3%. There were 2% false positive 
diagnoses. When at least three sputum specimens were examined the 
sensitivity rose to 91.4Ä in this study. 
Goossen described results of paraffin embedded sputum cytology 
from 414 patients of which 200 patients were histologically 
proven to have a lung malignancy. Correct positive rate was 
reported to be 49.5%. Three percent of the diagnoses were false 
positive. When three sputum specimens were examined the correct 
positive rate rose to 62.2%. 
Wacha analysed the proportion of correct positive diagnoses in 
492 patients with primary lung cancer and achieved 54%, without 
mentioning a percentage of false positive diagnoses. 
As yet the accuracy of sputum diagnosis using the Saccomanno 
method has only been reported once in a group of 400 patients by 
Pilottil^,
 who studying histologically confirmed primary lung 
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cancers only, reached a sensitivity of 56%. From each patient one 
to six sputum samples were examined. No specificity rate was 
given. 
Saccomanno^ studied 126 patients, of which 26 patients had 
primary lung cancer and found correct positive diagnoses in 88%. 
One to four sputum samples were examined per patient. There were 
no false positive diagnoses. 
Jayl* studied 244 patients of which 69 patients had 
lung cancer, including 6% metastatic lung malignancies and 
achieved a sensitivity of 50S and a specificity of 99%. Up to 
nine sputum specimens were examined per patient. 
From this survey it is clear that usually only patients with 
primary lung cancer are taken into account when studying the 
accuracy of sputum cytology, leaving out patients with metastatic 
lung malignancies. Also, many studies only deal with patients for 
whom histological proof of lung malignancy could be obtained. As 
yet the accuracy of the Saccomanno method for sputum cytology has 
not been examined in a large group of patients with primary as 
well as metastatic lung malignancies. This method of sputum 
processing is increasingly becoming the method of choice for the 
sputum cytologic diagnosis of malignant as well as premalignant 
lung lesions. 
The aim of the present study was to assess the diagnostic 
accuracy of sputum cytology according to Saccomanno in a large 
group of patients with malignant lung processes, primary as well 
as metastatic, and with premalignant lung lesions. 
In the literature as a rule either positivity rates or 
sensitivity and specificity rates are used to describe the 
diagnostic accuracy of sputum cytology. There is however no 
consistency in the number of sputum specimens examined per 
patient. Frequently the series of sputum examinations in a 
patient is interrupted before the correct diagnosis has been 
made. When using positivity rates many authors do not provide 
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information on the number of correct negative diagnoses nor on 
the number of false negative and false positive diagnoses. 
Furthermore calculating sensitivity rates are not considered 
the most appropriate way to describe the accuracy of sputum cyto-
logy because the probability of making a correct diagnosis is 
directly related to the number of specimens examined*?6-B,10, 
11,13,15,16, jhe number of sputum specimens to be examined for 
an optimal sensitivity of sputum diagnosis is not known. 
The sensitivity of sputum cytology can only be described 
adequately when the probability of making a correct sputum 
cytologic diagnosis is given as a function of the number of 
specimens. The most appropriate technique for obtaining these 
probabilities in the presence of "censored data" consists of 
calculating Kaplan Meier estimates and corresponding errors^. 
"Censored data" means that in some patients the exact number of 
examinations to arrive at a positive diagnosis is not known. In 
such patients an insufficient number of examinations was 
available, which indicates that more examinations to reach a 
correct positive diagnosis would have been necessary. Using these 
Kaplan Meier estimates the probability of a correct positive 
diagnosis for each number of sputum specimens (1-6) was 
calculated in this study. 
The only study concerning the Saccomanno method and 
cytologic typing accuracy is from Pilottil', handling about 
primary lung cancer patients. In the present study the 
applicability of this sputum method in predicting the specific 
type of a malignant lung process will be determined both for 
primary lung cancer and metastatic lung lesions. 
Furthermore it was investigated whether it is possible to 
give a "profile" of patients with a high or low chance for a 
correct diagnosis on sputum cytology. In order to come to such a 
profile the following parameters were analysed: tumor type, 
"patient characteristics", cellular composition of the sputum, 
influence of bronchoscopic examination and the presence of severe 
dysplastic cells in sputum. 
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In Chapter 1 the reliability and applicability of the 
Saccomanno sputum method for sputum cytology in a large group of 
patients with malignant lung processes, primary as well as 
metastatic, are reported. The probability of a correct positive 
diagnosis for each number of sputum specimens (1-6) was 
calculated using Kaplan Meier estimates, and not sensitivity 
rates. The cytologic typing accuracy of the Saccomanno method 
was also studied with special reference to the clinically most 
relevant subtypes of non small cell and small cell cancer. 
In Chapter 2 an examination of whether there are patient 
characteristics that are directly related to the accuracy of the 
Saccomanno method for sputumcytology in patients with primary as 
well as metastatic lung malignancies is reported. 
In the literature there are reports about the relationship 
between patient characteristics and the sensitivity of sputum 
cytology in primary lung cancer patienta^^-lA,18-20. in the 
present study both primary as well as metastatic lung 
malignancies are taken into consideration. Anamnestic and 
clinical patient characteristics are not related to the 
sensitivity but to the probability of a correct positive 
cytologic diagnosis on sputum. 
The presence or absence of alveolar macrophages is commonly 
used as the only quality parameter in sputumcy tology. A sputum 
specimen is generally considered to be of insufficient quality 
for cytologic diagnosis when an excess of necrotic material, 
blood or inflammatory cells is present 4,7,9,16-18,20-22. 
In Chapter 3 the relation between the cellular composition 
of sputum (all cell types) and the diagnostic accuracy of sputum 
cytology according to Saccomanno is investigated. 
Whether there is any influence of individual anamnestic and 
clinical patient characteristics on the cellular composition of 
the sputum specimens is also analysed. 
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The effect of bronchoscopical examination on sputum cytology 
has been described by several authorsl*»15,20,23-31. They state 
better quality and better results for postbronchoscopy - compared 
to prebronchoscopy - sputum cytology. In these studies the 
results were based on comparison of the diagnostic accuracy 
before and after bronchoscopy (specimen level). 
In Chapter 4 the effect of bronchoscopy on the quality and 
diagnostic results of sputum is analysed on a patient level using 
the paired Student-T-test, because there is a direct relation 
between patient characteristics and the outcome of sputum 
cytology. 
It is also examined whether there is a relation between certain 
patient characteristics and the quality and diagnostic outcome of 
postbronchoscopy sputum. The contribution of postbronchoscopy 
sputum to the final diagnosis of lung malignancy is analysed as 
well. 
Screening studies for the detection of early bronchogenic 
carcinoma have demonstrated, that intrabronchial squamous cell 
cancer may exist for a considerable period of time in an in situ 
or microinvasive stege'2-41, prior to this stage of development 
there is circumstantial evidence that before an in situ cancer is 
formed, epithelial abnormalities progress through varying degrees 
of dysplasia. Much work in this field has been done by Saccomanno 
in investigating uranium miners. 
Chapter 5 deals with the predictive value of the presence of 
severe dysplastic cells in sputum of patients who were suspected 
of having primary or metastatic lung malignancies. Also, whether 
there are anamnestic or clinical characteristics significantly 
related to the presence or absence of a malignant lung process in 
these patients is examined. 
In Chapter 6 the cytopathology of benign, premalignant and 
malignant lung processes is given with emphasis on differential 
diagnostic problems. 
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A B S T R A C T 
from 14ΘΘ patients satisfactory sputum was available for 
cytologic diagnosis. Overall diagnoses were correct in 85.4% of 
patients, false negative in 193 patients (13.OS) and false 
positive in 24 patients (1.6%). In patients with a malignant lung 
process cytologic diagnoses were correct in 228 patients (54.2%) 
and false negative in 193 patients (45.8%). 
In patients with primary lung cancer the proportion of 
correct positive diagnoses increased from 0.47 to 0.87 with 1 to 
5 sputum specimens examined. 
In patients with metastatic disease, the figures were 0.35 with 
one specimen examined and 0.38 with two and more sputum 
specimens. Cytologic typing accuracy was 67% for large cell 
carcinomas, 73% for adenocarcinomas, 91% for small cell lung 
cancers and 98% for squamous cell carcinomas. For the clinically 
most relevant groups of non small cell lung cancer and small cell 
lung cancer these figures were 99% and 91% respectively. 
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INTRODUCTION 
The cytologie examination of sputum is still the least 
uncomfortable method to obtain a diagnosis in patients suspected 
of lung cancer. The most common methods for sputum diagnosis have 
been direct smears from suspicious particles in fresh sputum^ 
and paraffin embedding and processing as used in histologic 
diagnosis^. 
A method for the preparation of cytologic smears from sputum 
material developed by Saccomanno' is becoming increasingly 
popular. 
Most studies concerning the accuracy of sputum cytology deal only 
with patients with primary lung cancer. In this study the 
accuracy of sputum cytologic diagnosis in patients with 
metastatic lung diseases is analysed as well. 
The aim of the present study is to assess the reliability 
and applicability of the Saccomanno method for sputum cytology in 
a large group of patients with malignant lung processes, primary 
as well as metastatic. 
The probability of making a correct diagnosis in sputum 
cytology is directly related to the number of specimens examined 
3»5-15. However the number of sputum specimens to be examined 
for an optimal sensitivity of sputum diagnosis is not yet known. 
Figures for sensitivity are therefore not considered the 
most appropriate way of describing the applicability of the 
Saccomanno sputum method in the diagnosis of malignant lung 
processes. Therefore the probability of a correct positive 
diagnosis is calculated as a function of the number of sputum 
examinations. The applicability of this sputum method in 
predicting the specific type of a malignant lung process will be 
determined. 
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MATERIALS ANO METHODS 
From January 197A through December 1980 a total of 2,466 
sputum specimens were processed from 1,618 newly admitted 
patients suspicious for a malignant lung process and diagnosed in 
the laboratory of cytopathology of the Radboud University 
Hospital of Nijmegen. 
From the majority of patients a three days pooled early morning 
sputum was received. The sputum specimen was collected in a 
fixative consisting of ethanol 50% carbowax R 2% 
(polyethyleneglycol 1500, Merck-Schuchardt, Hohenbrunn, 
W-Germany). According to Saccomanno's technique the sputum 
mixture was blended and centrifuged^. From the sediment a minimum 
of two smears was prepared. After air drying these were postfixed 
in ethanol 96% and stained according to the Papanicolaou 
procedure. 
In all patients a thorough review was made of all clinical 
records. Whenever these were incomplete or when a patient was 
discharged from clinical follow up necessary data were retrieved 
from general practitioners data files. From a total of 1,623 
patients follow up data with a minimal follow up period of two 
years (2-8 years) after the last visit to the hospital were 
collected in 1618. Five patients were lost to follow up. These 
were further excluded from this study. 
Clinical data such as previous pulmonary disease, sputum 
production and appearance of sputum, dyspnoea, smoking habits and 
previous medication or radiation therapy, results of lung 
function tests and results of bronchoscopic and bronchographic 
findings were collected. Patients with a malignant lung tumor 
were clinically staged according to the TNM classification of the 
International Union against Cancer. 
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All clinical data, combined with the coded results from 
cytologic and histologic examinations and, when relevant, autopsy 
findings, were entered for computer analysis. 
The sensitivity and specificity of the sputum cytologic diagnosis 
were calculated. Since the probability of finding the correct 
positive diagnosis in a patient depends on the number of sputum 
specimens which have been examined, the sensitivity of the 
Saccomanno method can only be described adequately when this 
probability is given as a function of the number of specimens. 
The most appropriate technique for obtaining these 
probabilities in the presence of "censored data" consist of 
calculating Kaplan Meier estimates and corresponding errors. 
"Censored data" means that in some patients the exact number of 
examinations to arrive at a positive diagnosis is not known. In 
such patients only an insufficient number of examinations was 
available, which indicates that more examinations to reach a 
correct positive diagnosis whould have been necessary. Using 
these Kaplan Meier estimates the probability of a correct 
positive diagnosis for each number of sputum specimens (1-6) was 
calculated. 
All cytologic specimens were reviewed by two cytopathologists 
with knowledge of the definitive histologic findings to establish 
β final cytologic diagnosis. 
By comparing cytologic and histologic diagnoses subdivided 
per specific tumor type, the degree of accuracy with which a 
histologic type of tumor can be predicted in sputum specimens 
processed with the Saccomanno method was analysed. 
RESULTS 
From the total group of 1,618 patients the existence of a 
malignant process in the lungs was confirmed in 476 patients 
(Table 1). 
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Table 1: Composition of patient groups; Follow Up diagnoses 
Total number of patients 1,618 
Malignant lung process 476 
Primary lung cancer 362 
Metastatic lung cancer 114 
In 1,142 patients the absence of a malignant tumor in the 
lungs was based on negative histologic findings or the absence of 
disease after a follow up of at least two years (2-8 years). A 
diagnosis of malignancy was made by histologic examination of a 
pulmonary lesion or of a regional metastasis in 402 patients. In 
74 patients the available histologic material was of insufficient 
quality to warrant a definitive diagnosis and in these patients a 
positive diagnosis of a malignancy was made on the basis of 
additional radiographical and clinical evidence. On this basis 
from the 476 patients, 362 were diagnosed as having a primary 
lung tumor, whereas 114 patients had a metastatic tumor in the 
lungs. 
Histologic diagnosis (Table 2) was made on bronchoscopical 
biopsies in 80 patients (19.9%), biopsies taken during 
mediastinotomy or thoracotomy in 5 patients (1.2%) or on surgical 
specimens from lobectomies, segmentectomies and pneumonectomies 
in 128 patients (31.8%). 
In 16 patients (3.9%) with primary tumors in the lungs the 
diagnosis was made on metastases and in 64 patients (15.9%) with 
metastatic spread to the lungs the histologic diagnosis was made 
on the primary tumor. In 109 patients (27.1%) the definitive 
diagnosis was made at autopsy. 
In table 2 the origin of the tissue material is given for the 
total group as well as subdivided for patients with primary 
tumors and those with lung metastases. 
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Table 2 : O r i g i n of t i s s u e m a t e r i a l used f o r h i s t o l o g i c d i a g n o s i s 
of lung m a l i g n a n c i e s 
Origin of t i s sue used Total 
for his to logic diagnosis N % 
Primary tumors Metastatic les ions 
N % N % 
Biopsy by bronchoscopy 
mediast inoscopy 
Biopsy at mediastinoscopy 
or thoracotomy 
Segmentectomy 
lobectomy 
pneumonectomy 
80 19.9/16.8 79 27.1/21.8 1 0 . 9 / 0.9 
5 1 .2 / 1.1 5 1 .7 / 1.4 
128 31.8/26.9 124 42.6/34.3 4 3 . 6 / 3.5 
Metastatic les ion of lung 80 19.9/26.8 16 5 .5 / 4.4 64 57 .7 /56 .1 
primary or primary tumor 
in lung metastasis 
Autopsy 
Subtotal 
109 27.1/22.9 67 23.0/1B.5 42 37.8/36.8 
402 100/84.5 291 100/80.4 111 100/97.4 
Unsatisfactory for 
h is to log ic diagnosis or 
not available 
74 /15 .5 71 /19 .6 / 2.6 
Total 476 100 362 100 114 100 
Upon c l i n i c a l s t a g i n g of the p a t i e n t s w i t h primary tumors 
( T a b l e 3) 77 p a t i e n t s (24 .2%) had Tl t u m o r s . 130 p a t i e n t s (40 .9%) 
had T2 tumors and 87 p a t i e n t s ( 2 7 . 4 S ) had T3 t u m o r s . From 24 
p a t i e n t s a c l i n i c a l s t a g i n g s c o r e was not a v a i l a b l e . 
Table 3 : C l i n i c a l s t a g i n g of primary lung c a n c e r s (UICC) 
Category of tumors N % 
Tl 
T2 
T3 
Not available 
77 
30 
87 
24 
24.2 
40.9 
27.4 
7.5 
Total 318 100 
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Frop the total group of 1,618 patients in 130 patients (8.05) 
the sputum material in successive specimens remained of such poor 
quality that a definitive diagnosis was not warranted (Table 4). 
This was the case in 55 patients (11.6%) with a malignant tumor 
and in 75 patients (6.6%) with non malignant disease. 
Table 4: Accuracy of cytologic diagnosis using the saccomanno sputum 
method in patients with and without lung malignanciea 
Sputum 
Cytologic 
Diagnosis 
Correct 
False negative 
False positive 
Subtotal 
Unsatisfactory 
for diagnosis 
Total 
Total number of 
patients 
N 
1271 
193 
24 
1488 
130 
1618 
% 
85.4 
13.0 
1.6 
100/92.0 
8.0 
100 
Malignant lung 
N 
228 
193 
-
421 
55 
476 
process 
% 
54.2 
45.8 
100/88.4 
11.6 
100 
No me 
lung 
N 
1043 
-
24 
1067 
75 
1142 
ilignant 
process 
% 
97.8 
2.2 
100/93.4 
6.6 
100 
The sputum was considered to be of insufficient quality when 
it consisted exclusively of squamous cells from the upper airways 
and atypical cells were absent and when the material was 
predominantly composed of necrotic material, blood or 
inflammatory cells. 
In total a correct cytologic diagnosis was made in 1,271 
patients (85.4%). In patients with a malignant disease 228 
(54.2%) were diagnosed correctly. In patients without malignant 
disease such was the case in 1,043 patients (97.8%). A false 
negative diagnosis was made in 193 patients (13.0%) which is 
45.8% of patients with a proven malignancy. A false positive 
diagnosis was made in 24 patients (2.2%) who on follow up were 
proven to have no malignant lung process. 
Since in 55 patients the sputum was unsatisfactory for 
cytologic diagnosis, the final group of patients with a malignant 
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lung process available for analysis of the sensitivity of the 
cytologic diagnosis consisted of 421 patients (Table 5). From 
these, 318 patients (75.5S>) had a primary lung cancer and 103 
(24.5%) had a metastatic process in the lungs. 
From the group of primary lung cancer patients, 300 (94.3SÍ) 
were men and 18 patients (5.7S>) were women (Table 5). In the 
group of metastatic tumors 62 patients were men (60.2%) and 41 
patients (39.8%) were women. From 421 patients with a malignant 
lung process (primary and metastatic) a total of 940 sputum 
specimens were of sufficient quality to be used for cytologic 
diagnosis. This is an average of 2.2 sputum specimens per 
patient. Of these specimens 735 (78.2%) were from patients with 
primary lung cancers and 205 (21.8%) were from patients with 
metastatic disease. 
Table 5: Study group of patients subdivided for primary and 
metastatic lesions and sex 
Sex of the 
patients 
Men 
Women 
Total 
Primary 
N 
300 
18 
318 
lung tumor 
% 
94.3 
5.7 
100 
Metastatic lung 
N % 
62 60.2 
41 39.8 
103 100 
tumor 
75.5 24.5 
The proportion of tumors diagnosed (dectection rate) 
differed greatly for primary tumors and metastatic tumors (Table 
6). For primary tumors the detection rate increased from 0.47 to 
0.60 with 1-5 Sputums investigated. For metastatic lesions the 
detection rate with one sputum examined was 0.35, with two to 
five specimens the detection rate remained at 0.36. It is 
customary to determine sensitivity and specificity of sputum 
cytologic diagnosis using these figures of correct positive, 
false positive and false negative results. Thus in our study 
"overall sensitivity" could have been calculated as 0.54 and 
"overal specificity" as 0.98. 
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Table 6: Detection rate of malignant lung processes with an 
increasing number of sputum specimens examined 
Number of sputum Primary Metastatic lung 
specimens diagnosed lung cancer malignancy 
N % N % 
150 
172 
185 
187 
191 
47.2 
54.1 
58.2 
58.8 
60.1 
36 
37 
37 
37 
37 
35.0 
36.0 
36.0 
36.0 
36.0 
Total 318 75.5 103 24.5 
For a more appropriate estimation of the sensitivity of the 
Saccomanno sputum method a calculation was made of the 
probability for making a correct diagnosis expressed as a 
function of the number of sputum specimens examined. 
Probability figures were calculated using Kaplan Meier 
estimates for censored data. In the group of 318 patients with 
primary lung cancers (Table 7, fig. 1) from whom one sputum 
specimen was available for diagnosis a positive diagnosis was 
made in 150 patients. The probability for a correct positive 
diagnosis on the first specimen as estimated by the proportion of 
patients with a correct positive cytologic diagnosis was 0.47. 
Using patients with two specimens, the proportion of correct 
diagnoses increased to 0.59, in 40 patients with three specimens 
it was 0.73, in 10 patients with four specimens it was 0.77 and 
in 5 and 2 patients with five and six specimens respectively it 
was 0.87. Of patients with metastatic disease, in 103 patients 
with one specimen submitted the proportion of correct positive 
diagnoses was 0.35. In patients with two to five specimens 
submitted the proportion of correct diagnoses remained at 0.38. 
Of 402 patients with a definitive histologic diagnosis of a 
specific type of lung tumor a cytologic diagnosis consistent with 
a lung malignancy as well as specifying a certain type of 
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Table 7: Probability of a correct positive cytologic diagnosis of sputum 
in patients with primary and metastatic lung cancer expressed 
as a function of the number of sputum specimens examined 
Primary lung cancer Metastatic lung malignancy 
Number of 
specimens 
submitted 
Number of 
patients 
Probability of a 
correct positive 
diagnosis * error 
Number of 
patients 
Probability of a 
correct positive 
diagnosis * error 
318 
96 
40 
12 
9 
2 
0.47 4. 0.03 
0.59 + 0.03 
0.73 * 0.04 
0.77 * 0.04 
0.Θ7 * 0.05 
0.87 * 0.05 
103 
26 
11 
3 
1 
0.35 * 0.05 
0.38 * 0.05 
0.38 * 0.05 
0.38 ± 0.05 
0.38 ± 0.05 
"Л. of correct positives 
100 
ΘΟ 
6 0 
4 0 -
2 0 
— · primary lungcancer 
—о metastatic lungmalignancy 
2 3 4 5 6 
number of sputum specimens 
Fig. 1. Probability of a correct positive cytologic diagnosis 
of sputum in patients with primary and metastatic lung 
cancer expressed as a function of the number of sputum 
specimens examined. 
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Table 8: COMPARISON OF CYTOLOGIC AND HISTOLOGIC DIAGNOSES IN PATIENTS WITH PRIMARY AND METASTATIC 
MALIGNANCIES OF THE LUNG 
Cytologic diagnosis Non small cell lung cancer Small cell Metastatic Row 
lung cancer cancer total 
Squamous cell carcinoma 
Adenocarcinoma 
Large cell 
anaplastic carcinoma 
Column Subtotal 
Small cell carcinoma 
Metastatic cancer 
Squamous cell Adeno 
carcinoma carcinoma 
79 
0 
1 
80 
1 
0 
98 
Large cell Subtotal 
anaplastic 
carcinoma 
N % N % 
2 
11 
2 
15 
0 
0 
73 
3 
1 
8 
12 
0 
0 
67 
84 
12 
11 
107 
1 
0 
99 
3 
0 
0 
3 
32 
0 
91 
5 
5 
3 
13 
0 
12 48 
92 
17 
14 
123 
33 
12 
Column total 81 15 12 108 35 25 168 
malignant tumor was available in 168 patients. Of these, 143 
patients had a primary lung tumor and 25 patients had a 
metastatic process. Squamous cell carcinomas were cytologically 
correctly predicted in 79 (98.5%) out of 81 patients (Table 8), 
adenocarcinomas in 11 (73%) out of 15 patients, large cell 
anaplastic carcinomas in 8 (67%) out of 12 patients and small 
cell anaplastic cancers in 32 (91%) out of 35 patients. A 
metastatic origin of the pulmonary lesion was correctly predicted 
in 12 (4BS) out of 25 patients. When subdivided according to the 
clinically relevant diagnoses "non small cell lung cancer and 
small cell lung cancer" 107 {99%) of 108 patients with non small 
cell cancers and 32 (91%) of 35 patients with small cell lung 
cancer were correctly diagnosed. Three patients with small cell 
lung cancer were cytologically incorrectly diagnosed as (poorly 
differentiated) squamous cell carcinomas and one patient with a 
squamous cell carcinoma was cytologically incorrectly diagnosed 
as small cell cancer. 13 (52%) of 25 metastatic lesions were 
diagnosed as non small cell cancer without reference to a 
possibly metastatic origin of the malignant tumor. 
DISCUSSION 
There are only very few studies in the literature dealing 
with the "sensitivity and specificity" of the Saccomanno method 
for sputum cytology^»5. This is the first well documented study 
of a large group of patients with lung malignancy including a 
high percentage (24.5%) of metastatic lung neoplasms, in which 
all the cytology material was processed using this technique. 
In describing the applicability of sputum cytology it is 
customary to give figures for sensitivity and specificity of the 
testi?. Sensitivity is used to characterise the incidence of true 
positive results obtained in patients known to have the disease 
(= "positivity in disease") and specificity to characterize the 
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incidence of true negative results obtained in patients known to 
be free of the disease (= "negativity in health"). 
Using the final results of sputum cytology in our study, 
figures for "overall sensitivity" would have been 0.54 and for 
"overall specificity" 0.98. 
Our rates of the diagnostic accuracy of the Saccomanno method for 
sputum cytology are comparable with the figures from the 
literature concerning all three methods for sputum cytology 
5-16, 18-29. 
However, since the number of tests applied to a patient 
varies considerably, since the optimal number of tests to be 
applied is not known and since a series of sputum tests in a 
patient is often discontinued before the "true" diagnosis is 
found, it is essentially not correct to calculate sensitivity and 
specificity. We have therefore applied an additional statistical 
evaluation technique to express the reliability and applicability 
of sputum cytology in detecting (or excluding) a malignant lung 
process. From all previous studies as well as from this study it 
has become evident that the probability of finding the correct 
positive diagnosis in a patient depends on the number of sputum 
specimens examined. 
The "sensitivity" of the Saccomanno method therefore is only 
completely described when the probability for a correct diagnosis 
is given as a function of the number of specimens examined. 
Generally the percentage of correct sputum diagnoses (e.g. 
positive for lung cancer) is directly calculated after 1, 2, 3 
and more examinations of sputum. This percentage in our opinion 
does not serve as a valid function, since in a large number of 
patients the series of sputum examinations is interrupted before 
the true diagnosis is found on the sputum. In this way a negative 
bias is introduced since "no examination" is treated as a 
"negative result". Therefore when the optimal number of tests 
necessary to reach a correct diagnosis is not known, it is better 
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to use a so called "censored data" technique, implying that the 
exact number of tests to be applied is not known, but only the 
lower boundary of this number of sputum examinations. The most 
appropriate technique to calculate the probability of a correct 
positive sputum diagnosis when no selectivity is present in the 
choice of discontinuing the sputum series, is by using the Kaplan 
Meier estimates*. 
The probability of finding the correct positive diagnosis 
when using the Saccomanno method for sputum cytology in patients 
with primary lung cancer increases sharply from 0.47 to 0.87 with 
the examination of 1 to 5 sputum specimens. At 6 sputum specimens 
the accuracy does not increase and is possibly levelling off. In 
patients with metastatic lung malignancies the probability of a 
correct positive diagnosis with this sputum method increases only 
from 0.35 to 0.38 with the examination of 1 to 2 sputum specimens 
and is levelling off with the examination of more sputum 
material. 
From these probalibity figures we can conclude that the 
number of specimens to be examined to achieve the highest 
possible proportion of correct positive diagnoses should be at 
least 5 specimens. Since the number of patients in our series who 
had more than 5 sputum specimens examined was very small we did 
not calculate probability figures. Possibly a higher probability 
could have been obtained with the examination of 6 or more sputum 
specimens. This means in practice that over 5 sputum specimens of 
satisfactory quality should be diagnosed as negative before the 
series of sputum examinations is discontinued under the 
assumption that a given patient does not have a primary malignant 
lung process. 
The low probability figures for a positive sputum diagnosis 
in patients with metastatic disease can be explained by the 
generally interstitial location of the metastatic process. As a 
rule metastatic tumors are not growing into the (open) airways as 
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is the case in most primary bronchial cancers. Therefore 
metastatic tumors as a rule will not exfoliate into the bronchial 
secretions. 
The Saccomanno sputum method enables the cytologist to 
predict the histomorphologic type with high accuracy for the four 
major subtypes of primary bronchial cancers. This typing accuracy 
ranged from a low of 67% in large cell anaplastic carcinomas to a 
high of 96% in squamous cell carcinomas. Subdivided for the 
clinically most relevant subtypes of "non small cell lung cancer" 
and "small cell lung cancer" this cytologic typing accuracy was 
99% and 91* respectively. 
In summary the Saccomanno sputum method is a useful and 
reliable diagnostic test in patients suspected of having primary 
lung cancer provided that as a rule the series of sputum tests is 
not discontinued before 5 sputum specimens have been diagnosed as 
negative. This sputum method gives a very good preservation of 
cytomorphologic characteristics of malignant cells, enabling the 
cytologist to differentiate with a high accuracy between non 
small cell lung cancer and small cell lung cancer. 
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ABSTRACT 
From 421 patients with a malignant lung process of whom 
samples of sputum of satisfactory quality were received patient 
characteristics relevant to this study were investigated. In 
patients with primary lung cancer, the presence of bloody sputum 
was highly significant from the point of view of its association 
with a correct positive cytologic diagnosis on sputum. In 
patients with metastatic lung cancer, the same relationship was 
noted. In patients producing bloody sputum the examination of at 
least three sputum samples revealed a proportion of correct 
positive diagnoses of 0.8Θ in primary lung cancer patients and of 
0.77 in patients with metastatic lung disaese. Furthermore, an 
association with a high sensitivity was found with low 
FEV-^-values (<50% of the Vital Capacity), tumors >24mm in 
diameter and squamous cell cancer type in patients with primary 
lung cancer. Central location of tumors correlated significantly 
better in both patient groups. 
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In a previous study we reported on the increasing orobabili-
ty of correct positive diagnoses with an increasing η Tiber of 
sputum examinationslO. From that study it was concluded that at 
least five sputum specimens had to be investigated before a spu­
tum series should be discontinued because of negative findings. 
Koss and associates6 reported on the relation between the 
location and the size of the tumor and the percentage of correct 
positive diagnoses in patients with lung malignancies. 
In the present study anamnestic and clinical patient charp-
teristics were related to the probability of a correct positive 
cytologic diagnoses using Saccomanno'a sputum technique. 
MATERIALS AND METHODS 
From January 1974 through December 1980, 476 patients with a 
confirmed malignant lung process had sputum submitted to the 
laboratory of cytopathology of the Radboud University Hospital of 
Nijmegen. 
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Unsatisfactory sputum specimens received for cytologic 
diagnosis in 55 patients resulted in 421 patients available for 
analysis of patient characteristics· Of these, 318 patients 
(75.5л) had a primary lung cancer; 300 (94.3%) were men and 18 
patients (5.7л) were women. In 103 (24.5%) of the 421 patients a 
metastatic lung malignancy was present; of these 62 (60.2%) were 
men and 41 patients (39.8%) were women. A total of 940 three days 
pooled early morning sputum specimens of sufficient quality for 
cytologic diagnosis were received (an average of 2.2 specimens 
per patient); 735 (78.2%) specimens were from patients with 
primary lung cancer and 205 (21.8%) were from patients with 
metastatic disease. The sputum was collected in a fixative 
consisting of ethanol 50% carbowax R 2% (polyethyleneglycol 1500, 
Merck-Schuchardt, Hohenbrunn, W-Germany). According to 
Saccomanno's technique, the sputum mixture was blended and 
cent rifugedll. From the sediment a minimum of two smears was 
prepared. After air drying, these were postfixed in ethanol 96% 
and stained according to the Papanicolaou procedure. 
A thorough review of all clinical records was carried out. 
Where necessary data were retrieved from general practitioners 
data files. Anamnestic data and clinical findings were collected. 
The following anamnestic data were investigated: referring 
agency: general practitioner, specialist, population X-ray 
screening for tuberculosis or plant health services. The presence 
of previous pulmonary disease and recent lung coeplaints: 
tingling or chronic cough, dyspnoea or wheezing, sputum 
production and the aspect of the sputum. Also data on saoking 
habits, previous Dedication (especially cytotoxic drugs), 
previous radiation therapy (of chest or otherparts) and 
occupational disease. Furthermore, any familial incidence of lung 
diseases (benign or malignant) was recorded. 
The clinical findings included lung function tests (as 
Forced Expiratory Volume (FEV) and Vital Capacity), the findings 
at chest X-ray exaaination, bronchoscopy and bronchography. From 
the chest X-ray the following parameters were investigated: 
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number of circumscribed tumors or diffuse growth pattern and size 
of the tumor(s). 
In order to establish the TNM-classification3 metastatic 
spread to regional lymph nodes or other sites was investigated 
radiographically. Furthermore atelectasis and tumor location 
(left/right/lobes) were entered for computer analysis. The 
bronchoscopic and bronchographic findings were divided into: 
occlusion of bronchial tree (non, partial, total) and location 
(central or peripheral). Central was defined as a location in the 
trachea, in the main stem of the bronchial tree, in an 
intermediate branch or in an opening of a segmental bronchial 
branch; peripheral as other than these sites. Finally, tumor 
tissue seen at bronchoscopy was documented as well. All clinical 
data, including sex and age of the patients, were combined with 
the coded results from the cytologic examinations and analysed by 
means of a computer. 
All cytologic specimens were reviewed by two 
cytopathologists (EK3R and GPV) with knowledge of the definitive 
histologic findings to establish a final cytologic diagnosis. 
Confirmation of a malignant lung process was achieved in 402 
patients based on histologic examination of pulmonary tissue or 
of regional metastases. In the remaining 74 patients, conclusive 
radiographical and clinical evidence was used. 
Using Kaplan-Meier estimates, for each number of sputum 
specimens (one to six) the relationship between the probability 
of a correct positive diagnosis and the clinical data was 
calculated. 
The Logrank-test was applied to test the differences in patient 
groups with respect to the probability of obtaining a correct 
positive sputum diagnosis as a function of the number of 
cytologically diagnosed specimens. 
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RESULTS 
The most appropriate technique for obtaining the probability 
of finding a correct positive cytologic diagnosis in sputum in 
the presence of "censored data" consists of calculating 
Kaplan-Meier estimates and corresponding errors^flO. "Censored 
data" means, that in some patients the exact number of 
examinations necessary to arrive at a positive diagnosis is not 
known. In such patients only an insufficient number of 
examinations was available, indicating that more examinations 
would have been necessary in order to reach a correct positive 
diagnosis. 
There were no significant relations between the Kaplan-Meier 
estimates for the probability of a correct positive sputum 
diagnosis and the following parameters: age, sex, referring 
doctor, previous pulmonary disease, tingling or chronic chough, 
wheezing, smoking habits, previous medication or radiation 
therapy, occupational disease, familial incidence of lung 
diseases, Vital Capacity, TNM-classification and the presence of 
atelectasis. 
In the group of patients with primary lung cancer, a very 
strong correlation was found between the aspect of the sputu· and 
the probability for making a correct cytologic diagnosis on 
sputum. 
For patients with bloody sputum (Table 1), the probability for a 
correct positive diagnosis of sputum ranged from 0.69 to 1.00 for 
one to four specimens examined. For patients with non-bloody 
sputum these figures were significantly (p<0.02) lower: 0.45 to 
0.71 (fig. 1). 
The same indication was found for patients with metastatic 
disease (Table 2). Bloody sputum scored a probability of 0.77 
(one - three specimens) compered with 0.38-0.51 for non-bloody 
sputum. 
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Table 1: Probability of a correct positive cytologic diagnosis on lung sputum 
in patients with ргіиагу Ііжк) cancer with or without bloody sputum, 
expressed as a function of the number of sputum specimens examined 
Number of Number of 
specimens patients with 
bloody sputum 
Probability of a 
correct positive 
diagnosis * error 
Number of 
patients with 
non bloody 
sputum 
Probability of a 
correct positive 
diagnosis * error 
77 
12 
5 
1 
0.69 * 0.05 
0.79 4- 0.06 
0.88 * 0.06 
1.00 
123 
39 
11 
4 
0.45 * 0.05 
0.65 * 0.05 
0.71 * 0.06 
0.71 * 0.06 
"/о of correct positives 
100 
8 0 
6 0 -
4 0 
2 0 
•—· bloody sputum 
о—о non bloody sputum 
—\ 1 1 1 
2 3 4 5 6 
number of sputum specimens 
Fig. Probability of a correct positive cytologic diagnosis 
on lung sputum in patients with primary lung cancer 
with or without bloody sputum, expressed as a function 
of the number of sputum specimens examined 
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Table 2: Probability of a correct positive cytologic diagnosis on lung 
sputum in patients with •etastatic lisig cancer with or without 
bloody sputum, expressed as a function of the number of sputum 
specimens examined 
Number of Number of 
specimens patients 
with bloody 
sputum 
Probability of a 
correct positive 
diagnosis * error 
Number of 
patients with 
non bloody 
sputum 
Probability of a 
correct positive 
diagnosis * error 
13 
2 
2 
0.77 + 0.12 
0.77 * 0.12 
0.77 * 0.12 
32 
9 
5 
1 
0.38 * 0.09 
0.51 * 0.11 
0.51 * 0.11 
0.51 * 0.11 
Table 3: Probability of a correct positive cytologic diagnosis on lung 
sputum in patients with primary ling cancer with or without low 
FEV^-values, expressed as a function of the number of sputum 
specimens examined 
Number of 
specimens 
submitted 
Number of 
patients 
with low 
FEVi (<503i 
of V.C.) 
Probability of a 
correct positive 
diagnosis * error 
Number of 
patients 
with high 
FEVi (>50!S 
of V.C.) 
Probability of a 
correct positive 
diagnosis * error 
21 
6 
1 
0.64 * 0.06 
0.Θ4 * 0.06 
0.84 * 0.06 
164 
51 
18 
6 
4 
0.49 ± 0.04 
0.63 * 0.04 
0.74 * 0.05 
0.74 * 0.05 
0.93 * 0.06 
Table 4: Probability of a correct positive cytologic diagnosis on lung sputum 
in patients with prlaary ling cancer with or without small lung 
tumors expressed as a function of the number of sputum specimens 
examined 
Number of 
specimens 
submitted 
1 
2 
3 
4 
5 
Number of 
patients with 
small (l-24nm) 
lung tumors 
40 
12 
4 
1 
Probability of a 
correct positive 
diagnosis ± error 
0.40 * 0.08 
0.50 * 0.09 
0.50 * 0.09 
0.50 * 0.09 
Number of 
patients with 
large (>24mm) 
tumors 
143 
38 
12 
3 
2 
Probability of a 
correct positive 
diagnosis * error 
0.54 * 0.04 
0.72 * 0.04 
0.84 * 0.05 
0.84 * 0.05 
0.92 * 0.06 
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A significant relation was also found between the Forced 
Expiratory Volu«· (F«Vl) and the probability of finding a correct 
cytologic diagnosis on sputum in patients with primary lung 
cancer (Table 3). In patients with low FEVl (< 50» of the Vital 
Capacity) probability figures for a correct positive sputum 
diagnosis were significantly (p<0.02) higher: 0.64-0.84 (one -
three specimens) compared with 0.49-0.74 in patients with a high 
FEVl (fig· 2). In metastatic lung disease, patient groups were 
not sufficiently large for statistical analysis on this 
parameter. 
Another significant (p<0.03) correlation in primary lung 
cancer patients, was found between tunor size on the chest-X-ray 
and the probability of finding a correct positive sputum 
cytologic diagnosis (Table 4). 
% of correct positives 
100 -ι 
80 -
F i g . 
6 0 
40 -
2 0 
• — · FEV, <50% of VC 
о—о FEV, > 5 0 % o f VC 
ι ι ι ι ι 
1 2 3 4 5 6 
number of sputum specimens 
P r o b a b i l i t y of a c o r r e c t p o s i t i v e c y t o l o g i c d i a g n o s i s 
on l u n g sputum i n p a t i e n t s w i t h p r i m a r y l u n g cancer 
w i t h or w i t h o u t low F E V ^ - v a l u e s , expressed as a 
f u n c t i o n of the number of sputum specimens examined 
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"/о of correct positives 
100 
8 0 
6 0 
4 0 
2 0 
•—· tumor > 2¿ mm 0 
о—о tumor <.2i mm 0 
2 3 4 5 6 
number of sputum specimens 
F i g . P r o b a b i l i t y o f a c o r r e c t p o s i t i v e c y t o l o g i c d i a g n o s i s 
on l u n g s p u t u m i n p a t i e n t s w i t h p r i m a r y l u n g c a n c e r 
w i t h o r w i t h o u t s m a l l l u n g t u m o r s , e x p r e s s e d as a 
f u n c t i o n o f t h e number o f s p u t u m s p e c i m e n s e x a m i n e d 
Table 5: P r o b a b i l i t y of a c o r r e c t p o s i t i v e c y t o l o g i c d i a g n o s i s on lung sputum 
i n p a t i e n t s w i t h pr iaary l i n g cancer subdiv ided f o r the l o c a t i o n o f 
the tumors, expressed as a f u n c t i o n of the number of sputum specimens 
examined 
Number of Number of pa-
specimens t i e n t s w i t h 
submit ted c e n t r a l l y l o ­
cated tumors 
Probability of a 
correct positive 
diagnosis ± error 
0.59 * 0.04 
0.73 * 0.04 
0.80 ± 0.05 
0.Θ6 * 0.07 
1.00 
Number 
patient 
of 
s with 
peripherally 
located tumors 
112 
32 
15 
4 
2 
Probabil i ty of a 
correct posit ive 
diagnosis * error 
147 
35 
8 
3 
2 
0.44 * 0.05 
0.58 * 0.06 
0.69 * 0.06 
0.69 * 0.06 
0.85 * 0.11 
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In patients with small primary lung tumors (l-2Amm), the 
probability of finding a correct positive diagnosis of sputum was 
significantly lower compared with larger primary lung tumors. 
Probabilities ranging from 0.40 to 0.50 for the small cancers 
(<24mm) (one to four specimens) compared with 0.54-0.84 for 
larger cancers (>24mm) (one to four specimens) (fig. 3). 
In patients with metastatic disease no significant 
correlation was found between the size of the tumor(s) and the 
probability of a correct positive diagnosis on sputum. 
Furthermore, a significant (p<0.01) relation was found 
between the location of a tuaor and the probability of finding a 
correct positive diagnosis (Table 5). In patients with a 
centrally located primary tumor, there was a significantly higher 
probability for a correct positive cytologic diagnosis: 0.59-1.00 
(one - five specimens) compared with a probability of 0.44-0.85 
in patients with tumors which were located peripherally (fig. 
4). For Metastatic disease, these figures were for central 
tumors: 0.73 (one - two specimens) compared with 0.22-0.27 (one -
two specimens) for peripheral tumors (Table 6) (p<0.01). 
A squamous cell cancer type in patients with ргіяагу lung 
cancer was related with significantly (p<0.02) higher probability 
figures for a correct sputum diagnosis 0.58-1.00 (one to five 
specimens) when compared with non squamous cell cancer 0.43-074 
(Table 7, fig 5). Furthermore the combined data showed a tendency 
by the physician to submit less frequently sputum material for 
cytologic diagnosis in patients with chronic lung complaints 
compared with patients who had no lung complaints or only 
complaints of short duration. The same trend was evident in 
patients with a low Vital Capacity (25-75%) compared with 
patients having high Vital Capacity values (>75Ж). 
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% of correct positives 
100 η 
" 
о -
_ 
6 0 -
4 0 -
-
2 0 -
/ 
/ / -/ 
τ У 
/ / 
Г ' ' 
У J 
' 
/ > / / / / / s 
_ / τ / 
ι- / 
/ / / 
/ I /1 / ч- - ι - / 
τ τ / / / f 
/ / / s 
χ 
·—% central tumor 
о—о peripheral tumor 
l i l i l í 
2 3 4 5 6 
number of sputum specimens 
F i g . P r o b a b i l i t y o f a c o r r e c t p o s i t i v e c y t o l o g i c d i a g n o s i s 
on l u n g s p u t u m i n p a t i e n t s w i t h p r i m a r y l u n g c a n c e r 
s u b d i v i d e d f o r t h e l o c a t i o n o f t h e t u m o r s , e x p r e s s e d as 
a f u n c t i o n o f t h e number o f s p u t u m s p e c i m e n s e x a m i n e d 
Table 6: P r o b a b i l i t y of a co r rec t p o s i t i v e c y t o l o g i c d iagnosis on lung sputum 
i n p a t i e n t s w i t h Metastatic І і л д cancer subdiv ided f o r t he l o c a t i o n 
of the tumors, expressed as a f u n c t i o n of the number o f sputum 
specimens examined 
Number of 
specimens 
submit ted 
1 
2 
3 
4 
5 
Number of pa­
t i e n t s w i t h 
c e n t r a l l y l o ­
cated tumors 
11 
2 
P r o b a b i l i t y of a 
c o r r e c t p o s i t i v e 
d i a g n o s i s * e r r o r 
0.73 * 0.13 
0.73 * 0.13 
Number of 
p a t i e n t s w i t h 
p e r i p h e r a l l y 
l o c a t e d tumors 
42 
14 
5 
3 
1 
P r o b a b i l i t y o f a 
c o r r e c t p o s i t i v e 
d iagnos is * e r r o r 
0.21 * 0.06 
0.27 * 0.0 
0.27 * 0.08 
0.27 * 0.08 
0.27 * 0.08 
Table 7: Probability of a correct positive cytologic diagnosis on lung sputum 
in patients with ргівагу lung cancer with or without squamous cell 
cancer, expressed as a function of the number of sputum specimens 
examined 
Number of Number of pa- Probability of 
specimens tients with a correct poai-
aubmitted squamous cell tive diagnosis 
lung cancer * error 
Number of pa­
tients with non-
squamous cell 
lung cancer 
Probability of a 
correct positive 
diagnosis ± error 
1 
2 
3 
4 
5 
125 
28 
9 
3 
1 
0.58 * 0.04 
0.75 * 0.05 
0.80 A 0.05 
0.80 * 0.05 
1.00 
122 
37 
10 
1 
1 
0.43 * 0.05 
0.57 * 0.05 
0.74 + 0.07 
0.74 + 0.07 
0.74 * 0.07 
% of correct positives 
100 
8 0 -
6 0 
4 0 
20 
•—»squamous cell cancer 
e—о other concertype 
— ι 1 1 1 
2 3 4 5 6 
number of sputum specimens 
Fig. 5. Probability of a correct positive cytologic diagnosis 
on lung sputum in patients with primary lung cancer 
with or without squamous cell cancer, expressed as a 
function of the number of sputum specimens examined 
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DISCUSSION 
In this study a correlation between the probability of a 
positive cytologic diagnosis on sputum processed by the 
Saccomanno method and patient characteristics was investigated. 
In the literature very few studies discuss this subject'. 
This is the first well documented study concerning this 
subject in a large group of patients with lung malignancy 
including a high percentage (24,5й) of patients with metastatic 
lung cancer. 
Patient characteristics were correlated with the probability of a 
correct positive sputum diagnosis using Kaplan-Meier 
estimates?,5,10 and not with sensitivity figures for a 
cytologic diagnosis. 
From Table 1-3 (figs. 1-5) it is concluded, that the patient 
characteristics, associated with the highest probability of 
finding the correct sputum cytologic diagnosis in patients 
suspicious for primary lung cancer, are: bloody aputua, low 
FEVi-values, large lung tunors (>24mm), central location of the 
tumor and squaaous cell cancer type. In patients with metastatic 
lung cancer, significant patient characteristics for the highest 
probability of a correct sputum diagnosis were: bloody sputua and 
central location of the tuaor. 
Using the Log rank test we were able to avoid the expression 
of spurious correlations between patient characteristics and 
sputum diagnosis which would have confused the results of the 
study. Comparison of our results with those of the literature 
revealed not only differences in calculation of the diagnostic 
accuracy, but also in correlations with patient characteristics. 
We could not confirm the finding that the left upper lobe yields 
significantly better sputum cytologic results', neither did we 
find better results for tumors located in the right lung and in 
patients over the age of 70 yeers-^. 
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The following conclusions may be drawn from our study: 
The significant correlations found between the patient 
characteristics and the highest probability of a correct positive 
diagnosis on sputum cytology can be explained, by means of 
continuity between the trachea, bronchial tree and the tumor. 
Bloody sputum will be the most important patient characteristic 
associated with a high probability of a positive sputum cytologic 
diagnosis. Thus, in patients with bloody sputua the cytologic 
examination of their sputum is the easiest way to establish a 
correct positive diagnosis without the necessity to refer to more 
complicated procedures. 
With the examination of at least three pooled sputua 
speciaens, the probability to make a correct positive sputum 
diagnosis in patients with primary lung cancer is 0.88 and in 
patients with metastatic lung cancer this probability is 0.77. 
Furthermore, the results of this study showed a trend to submit 
sputum material less frequently from patients with chronic lung 
complaints and/or low Vital Capacity values. The reason might be 
that in these patients who usually are under long term 
surveillance, physicians tend to abide at an earlier stage by a 
negative result of the sputum examination. This results in a high 
false negative rate since the sputum series is curtailed too 
early reducing the probability of a positive sputum diagnosis. 
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ABSTRACT 
From 410 patients with either a primary or a metastatic 
malignant lung process, the cellular composition of the sputum 
specimens was analysed in relation to the diagnostic accuracy of 
sputum cytology and in relation to anamnestic and clinical 
patient characteristics. 
In patients with primary lung cancer sputum samples with 
correct positive diagnoses contained significantly more cells 
from the deeper airways such as alveolar macrophages and 
bronchial columnar cells than sputum specimens with a false 
negative diagnosis, even though these cell types were present in 
both types of specimens. 
In sputum samples of patients with metastatic lung malignancies 
differences in cellular composition of specimens with correct 
positive and false negative diagnoses were not significant. 
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INTRODUCTION 
The most commonly used quality parameter in sputum cytology 
is the presence or absence of alveolar macrophages. A sputum 
specimen is generally considered of insufficient quality for 
cytologic diagnosis when the material is composed predominantly 
of necrotic material, blood or inflammatory cellsl-8|ll. In 
this study we investigated the relationship between the cellular 
composition of sputum and the diagnostic outcome of sputum 
cytology in patients with primary or metastatic malignant 
processes of the lung. 
Furthermore, the influence of β number of individual 
anamnestic and clinical patient characteristics on the cellular 
composition of the sputum specimens was analysed. 
MATERIALS AND METHODS 
The cellular composition of lung sputum was analysed in a 
group of 410 patients with a confirmed malignant process of the 
lung. 
Included in the study were 57Θ sputum specimens from 310 patients 
with primary lung cancer and 15Θ specimens from 100 patients with 
a metastatic lung malignancy. As a control set of "normal 
patients", 45 sputum samples from 27 patients whose diagnoses 
were proven to be correctly negative were added as "negative 
controls". 
The sputum was collected in a fixative consisting of ethanol 
50S carbowax R 2% (polyethyleneglycol 1500, Merck-Schuchardt, 
Hohenbrunn, W. Germany). The sputum mixture was blended and 
centrifugad according to Saccomanno's techniquell. From the 
sediment a minimum of two smears was prepared. After air drying, 
these were postfixed in ethanol 96% and stained according to the 
Papanicolaou procedure. 
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Sputum specimens were considered to be of insufficient 
quality for cytologic diagnosis when they consisted exclusively 
of squamous cells from the upper airways in the absence of 
atypical cells, or when the samples consisted mainly of necrotic 
material, erythrocytes or inflammatory cells. 
From sputum samples of sufficient quality 1000 cells per specimen 
were counted. Cells counted were alveolar macrophages (A), 
columnar bronchial epithelial cells (B), squamous cells (C), 
squamous metaplastic cells (D), dysplastic epithelial cells (E), 
tumor cells (F) and non classifiable atypical cells -"unknowns"-
(G). The cells were counted within six circular areas which were 
marked on each slide with the help of a matrix. 
As we reported earlier'»!" a thorough review of all 
clinical records was carried out to gather anamnestic and 
clinical data ("patient characteristics"). When necessary, data 
were retrieved from general practitioners data files as well. 
Histologic examination or conclusive radiographical and clinical 
evidence provided a definitive diagnosis of malignancy'. The 
relation between a number of "patient characteristics" and the 
diagnostic outcome of sputum cytology was described in a previous 
рарегЮ. Patient characteristics analysed for their influence on 
the cellular composition of the sputum were: sex, age, lung 
complaints, smoking habits, type of sputum (bloody or 
non-bloody), lung function test-results, bronchoscopical 
findings, tumor size, tumor location, TNM stage, and histological 
type of the tumor. All clinical and cytopathological data were 
coded and stored for correlation studies and statistical 
analysis. To determine the relation between the diagnostic 
accuracy of sputum cytology and the cellular composition of the 
sputum the Mann Withey U test or the Kruskal Wallis test were 
used. When there was an unequal distribution of the values from 
the sputum countings median values were used for analysis, 
instead of average values per group. To establish a final 
cytologic diagnosis, all sputum specimens from this study were 
reviewed by two cytopathologists (EK3R and GPV) who had previous 
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knowledge of all pertinent clinical findings and of the final 
histologic diagnosis. 
R E S U L T S 
To determine whether the cellular composition of sputum was 
significantly related to anamnestic and clinical data of 
individual patients ("patient characteristics") a correlation was 
made between these patient characteristics and sputum composition 
in those patients who participated in the study group with at 
least three sputum specimens. 
From the total group of 410 patients, 129 patients had three 
or more sputum specimens examined. Of these, 106 patients had a 
primary lung malignancy and 23 patients were known to have a 
metastatic process. From 75 patients (71%) with a primary malig-
nancy three or more sputum specimens were of sufficient quality 
for cytologic evaluation. The group of 23 patients with a 
metastatic lung process and at least three sputum specimens, was 
considered too small for this particular analysis. 
When comparing the two subgroups of patients with a primary 
lung malignancy, having either three high quality specimens or 
one to three specimens of insufficient quality no significant 
differences could be found with respect to the patient 
characteristics. 
It was therefore considered correct to analyse relations between 
the cellular composition of sputum, the diagnostic outcome of 
sputum cytology and patient characteristics on specimen level. 
From the total group of patients sputum specimens were 
subdivided into four groups according to the accuracy of the 
cytologic diagnosis (correct positive or false negative) and the 
character of the lung malignancy (primary or metastatic). To 
these were added negative controls (group 5, table 1 ) . 
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Table 1: Sputum specimens subdivided for accuracy of the cytologic 
diagnosis and the primary or metastatic character of the 
lung tumor 
Group 
number 
1 
2 
3 
4 
5 
Accuracy of 
cytologic 
diagnosis 
correct positive 
false negative 
correct positive 
false negative 
correct negative 
Character of 
lung tumor 
primary 
primary 
metastatic 
metastatic 
negative cont 
the 
;rol 
Number 
sputum 
of 
specimens 
313 
265 
43 
115 
45 
Number of 
patients 
310 
100 
27 
from the total group of 410 patients 736 sputum specimens of 
sufficient quality were available for analysis of the cellular 
composition of sputum. In 310 patients with a primary lung tumor 
there were 265 sputum specimens from patients with a false 
negative diagnosis and 313 sputum specimens from patients with a 
correct positive diagnosis. In 100 patients with a metastatic 
lung process, 115 sputum specimens with a false negative 
diagnosis and 43 sputum specimens from patients with a correct 
positive diagnosis could be analysed. There were 45 sputum 
specimens from 27 control patients with a correct negative 
diagnosis. 
In the total group of patients for all sputum specimens 
correlations were made between the cellular composition of 
sputum, subdivided for seven different cell types (Α-G) and the 
accuracy of the cytologic diagnosis (Table 2 ) . 
In the whole group of patients (primary and metastatic) all 
cell types with the exception of squamous cells (C) and squamous 
metaplastic cells (D) were present in significantly higher 
concentration (p<0.0001) in specimens with a correct positive 
cytologic diagnosis (groups 1 and 3) when compared with specimens 
with a false negative diagnosis (groups 2 and 4 ) . As far as non 
malignant cells were concerned this was somewhat less evident for 
bronchial columnar cells (B)(P=0.03) than it was for alveolar 
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Table 2: Comparison of cellular composition of sputum specimens 
with correct positive (CP), false negative (FN) and 
corect negative (CN) diagnoses. 
Specimen group 
1+3 vs 2+4 (CP 
1 vs 2 (CP 
3 vs 4 (CP 
5 vs 2 vs 4 (CP· 
- FN) 
- FN) 
- FN) 
-FN-FN) 
A 
»#* 
»*» 
(*) 
В 
#* 
* 
* 
С ell types!) 
С D 
*** _ 
*#* _ 
E 
*#* 
*·· 
• 
G 
# 
*** 
A = Macrophages; В = bronchial columnar cells; С = squamous 
cells; 0 = squamous metaplastic cells; E = dysplastic cells; G 
= un-classifiable atypical cells 
0.05 < Ρ < 0.1 = (*) 0.001 < Ρ < 0.01 = ** 
0.01 < Ρ < 0.05 = * 0.0001 < Ρ < 0.001 = *** 
1) ρ values of Mann Withney U test 
macrofages(A) and dysplastic cells (Ε)(Ρ<0.0001). Squamous cells 
(С) were found in significantly lower percentages in sputa with a 
correct positive diagnosis. 
When comparing the cellular composition between specimens 
with a correct positive and a false negative diagnosis in 
patients with a primary lung tumor the same pattern evolved 
(Table 2, group 1 vs. group 2). Again, the percentage of squamous 
metaplastic cells did not differ significantly between specimens 
with a correct positive or a false negative diagnosis. 
When comparing the cellular composition between specimens 
with a correct positive and a false negative diagnosis in 
patients with a metastatic lung tumor (groups 3 and 4, Table 2), 
the test results were completely different. Only for the 
percentage of non-classifiable atypical cells (G) was a 
significant difference (P<0.0001) found between the two classes 
of specimens. The numbers of non-malignant cell types did not 
differ significantly. 
When comparing the cellular composition of sputum specimens 
with a false negative diagnosis from patients in the total group 
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Table 3: Cellular composition of sputum in patients with primary 
lung cancer. Percentage of sputum samples (N=378) with 
indicated number (*) (per 100Q cells counted) of 
specific cell type present, subdivided for correct 
positive and false negative cytologic diagnoses. 
Number* 
of 
cells 
counted 
100 
200 
300 
400 
500 
600 
700 
Θ00 
900 
1000 
Alveolar macrophages 
Corr.P. 
% 
3Θ.0 
24.6 
14.1 
8.3 
5.1 
2.6 
4.4 
1.9 
0.4 
0.6 
100.0 
False N 
% 
51.3 
22.3 
10.6 
3.7 
3.8 
2.3 
2.6 
1.1 
1.9 
0.4 
100.0 
(A) Squamous epi 
Corr .P. 
% 
2.9 
1.9 
4.5 
5.4 
5.4 
Θ.3 
9.3 
19.2 
21.7 
21.4 
100.0 
thelial cells(C) 
False N 
% 
1.5 
2.7 
1.5 
3.0 
3.4 
6.4 
7.5 
9.5 
22.6 
41.9 
100.0 
number of cells of specified cell type in 1000 cells counted 
(groups 2 and 4) with the cellular composition of sputum 
specimens from the correct negative controls (group 5) the number 
of alveolar macrophages (A) was not significantly higher in 
sputum specimens from correct negative controls (P=0.07). 
The number of dysplastic epithelial cells (E) was significantly 
higher (P=0.04) in sputa from negative controls. The percentage 
of bronchial columnar cells (B) was significantly higher in 
correct negative specimens (P<0.04). 
For patients with primary lung cancer differences in the 
distribution of the percentages of alveolar macrophages and of 
squamous epithelial cells in sputum specimens with correct 
positive and false negative diagnoses are given in table 3. The 
higher proportion of alveolar macrophages and the smaller 
proportion of squamous epithelial cells per 1000 cells counted in 
sputum specimens with a correct positive diagnosis are clearly 
recognizable (figs. 1 and 2). 
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% of sputum samples 
50 
'I 
30 
20 
10 
| | correct positive π «313 
false negative η 265 
1 
1 
<100 «200 <300 Í400 '< 500 < 600 4700 < 600 < 900 «1000 
number of alveolar macrophages per 1000 cells 
Cellular composition of sputum in patients with primary 
lung cancer. Percentages of sputum samples (N=578) with 
indicated number of cells present: alveolar 
macrophages. 
·/„ ol sputum samples " 
40 
30 
20 
10 
| | correct positive n.313 
bJsJ false negative η s 265 
^fi~)^ 
ші 
ι 
ι 
ri. 1 
И" 
100 ' 200 ' 300 400 500 6O0 70O 600 900 1000 
number of squamous cells per 1000 cells 
Cellular composition of sputum in patients with primary 
lung cancer. Percentages of sputum samples (N=578) with 
indicated number of cells present: squamous cells. 
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Table 4: Relation between patient characteristics and the cellular 
composition of sputum specimens* 
Patient characteristics Sputum cell type 
0.01 
0.003 
0.001 
0.09 
0.004 
0.001 
0.02 
ce 
0.06 
0.001 
Age > 60 years 0.01 
Stop at bronchoscopy 0.02 
Tumor location in R lung 0.04 
Tumor location UL, ML, LL 0.09 UL 0.01 UL/ML 
Tumor location 0.004 
CE/PE pe 
Tumor size > 50mm 
Bloody sputum 
FeVi Q-bQ% of VC 
Male sex 
Tumor type SCC 
* = Ρ values of Mann-Withey U test or Kruskal-Wallis test A = macrophages; 
В = bronchial columnar c e l l s ; С = squamous c e l l s ; D = squamous metaplastic 
c e l l s ; E = dysplastic c e l l s ; F = tumor c e l l s ; G = un-classif iable atypical 
c e l l s 
UL = upper lobe; ML = middle lobe; LL = lower lobe; 
CE = c e n t r a l ; PE = peripheral; SCC = squamous c e l l cancer 
The a n a l y s i s of t h e r e l a t i o n between s p e c i f i c p a t i e n t 
c h a r a c t e r i s t i c s and t h e c e l l u l a r c o m p o s i t i o n of sputum i n 
p a t i e n t s w i t h p r i m a r y l u n g cancer showed t h e f o l l o w i n g r e l a t i o n s 
( T a b l e 4 ) . 
A s i g n i f i c a n t l y h i g h e r number of squamous m e t a p l a s t i c c e l l s 
(D) (P<0.01) was found i n p a t i e n t s over 60 y e a r s of age compared 
t o p a t i e n t s under 60 y e a r s of age. 
I n p a t i e n t s w i t h a c o m p l e t e s t o p seen at bronchography or at 
b r o n c h o s c o p y , the number of tumor c e l l s (F) i n sputum specimens 
was s i g n i f i c a n t l y h i g h e r ( P = 0 . 0 2 ) . I n p a t i e n t s w i t h an i n c o m p l e t e 
s t o p t h e combined number of b r o n c h i a l columnar c e l l s and squamous 
m e t a p l a s t i c c e l l s tended t o be h i g h e r , but t h i s d i f f e r e n c e was 
not s i g n i f i c a n t ( P = 0 . 0 9 ) . In p a t i e n t s w i t h a tumor i n the r i g h t 
l u n g t h e number of a l v e o l a r macrophages i n sputum specimens was 
s i g n i f i c a n t l y h i g h e r (P=0.04) than i n p a t i e n t s w i t h a tumor i n 
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the left lung. Sputum specimens from patients with tumors located 
in the upper lobe (vs localisation in middle or lower lobe) 
tended to contain more macrophages but this difference was not 
significant (P=0.09). In patients with a tumor location in the 
upper (UL) and lower lobes the combined number of macrophages, 
bronchial columnar cells and squamous metaplastic cells was 
significantly higher, (P=0.02) when compared with patients with 
tumors in the lower and middle lobes (ML). In the latter group of 
patients the number of squamous epithelial cells was 
significantly higher (P<0.01). 
In patients with a peripheral (vs central) location of the 
tumors the number of alveolar macrophages was significantly 
higher (P=0.04). The number of tumorcells was significantly 
higher in patients with centrally located tumors (P=0.02). Tumor 
size was not significantly related to cellular composition of 
sputum although in patients with large tumors (50-250mm in 
diameter) the number of tumorcells almost reaches statistical 
significance (P=0.06). 
In patients who produced bloody sputum (vs non-bloody sputum) the 
number of tumor cells counted was significantly higher 
(P<0.001). 
In patients with a low Vital Capacity (25-755») the number 
of squamous epithelial cells tended to be higher (P=0.06) than in 
patients with a relatively normal Vital Capacity (75-100Й). 
A low FeVi value (0-508 of VC) was significantly associated with 
a higher number of squamous metaplastic cells (P<0.01) whereas 
the number of dysplastic cells was not significantly different 
(P=0.09) in these patients. In male patients (vs female patients) 
significantly higher numbers were counted for squamous 
metaplastic cells (P=0.003) and dysplastic cells (P=0.004). 
Atelectasis, previous lung disease and dyspnoea showed no 
significant relationship with sputum composition. In patients 
with a history of wheezing the number of bronchial columnar cells 
(B) tended to be higher (P=0.07) whereas in patients without 
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such a history the number of squamous metaplastic cells (D) was 
significantly higher (P=0.03). 
When subdivided for tumortype (squamous cell cancer, large 
cell anaplastic cancer, small cell anaplastic cancer and 
adenocarcinoma) significantly higher numbers of tumorcells (F) 
(P<0.001) and dysplastic cells (E) (P<0.001) were found in 
patients with squamous cell cancer. The second highest percentage 
of tumor cells was found in sputum from patients with small cell 
anaplastic cancers followed by patients with large cell 
anaplastic cancer. The lowest number of tumor cells was found in 
patients with adenocarcinomas. 
The distribution of the percentages of tumor cells counted 
per 1000 cells in sputum specimens from patients with primary 
lung cancer is given in table 5. In 93.3S> of specimens less then 
10S tumorcells (100/1000) were counted. In 74.BS of specimens the 
number of tumor cells counted was less than 2S (20/1000) and in 
64.2% of specimens less than IS (10/1000) of the cells counted. 
Table 3: Cellular composition of sputum in patients with primary 
lung cancer. Percentage of sputum samples (N=313) with 
specified number of tumor cells per 1000 cells counted 
Number* Percentage of sputum Number 
of tumor samples with speci- of tumor 
cells fied number of cells cells 
N=< S cm S N=< 
Percentage of sputum 
samples with speci­
fied number of cells 
S cm S 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
64.2 
10.6 
3.Θ 
7.4 
2.5 
1.3 
2.2 
-
1.0 
0.3 
64.2 
74.8 
78.6 
86.0 
88.5 
89.8 
92.0 
-
93.0 
93.3 
100 
200 
300 
400 
500 
600 
700 
BOO 
900 
1000 
93.3 
3.2 
0.9 
0.4 
0.9 
0.3 
0.4 
-
-
0.6 
93.3 
96.5 
97.4 
97.8 
98.7 
99.0 
99.4 
-
100 
number of tumor cells per 1000 cells counted. 
60 
DISCUSSION 
In sputum specimens with a correct positive diagnosis the 
relative percentages of alveolar macrophages, bronchial columnar 
cells and dysplastic cells were significantly higher and the 
relative percentage of squamous epithelial cells was 
significantly lower than in specimens with a false negative 
diagnosis. In sputum specimens from patients with metastatic lung 
malignancies these cell types did not serve as indicators for a 
higher chance for a correct positive diagnosis. Between correct 
positive and false negative specimens only the number of 
un-classifiable atypical cells (unknowns) differed significantly 
(p <0.0001). 
This indicates that in the cytologic diagnosis of metastatic 
processes many malignant cells are often not recognised as 
belonging to a certain type of tumor, but on the basis of their 
atypicality are taken as supportive evidence for the presence of 
a malignant process. In patients with primary lung tumors this 
group of unclassifiable cells plays a less important role, most 
likely because atypical cells are more often recognized as 
belonging to a specific type of tumor. 
The cellular composition of sputum specimens in correct 
negative controls showed no significant or only slightly 
significant differences with the cellular composition of 
specimens with a false negative sputum diagnosis. 
From the results of this study it is evident that the mere 
presence of alveolar macrophages cannot serve as an indicator for 
good sputum, since these cells, though in lower numbers, are 
consistently found in sputum specimens with false negative sputum 
diagnoses. Good quality sputum with the highest chance for a 
correct positive diagnosis, as a rule contains a relatively high 
proportion of alveolar macrophages, bronchial columnar cells and 
dysplastic cells. 
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These significant parameters for a good quality sputum were found 
in the total group of patients as well as in patients with a 
primary lung malignancy. The number of dysplastic epithelial 
cells was slightly significantly higher in negative controls. 
When analysed for patient characteristics the composition of 
the sputum showed the following relations. Squamous metaplastic 
cells were found in significantly higher numbers in patients over 
60 years of age. Cellular composition of sputum as indicated by 
the presence of alveolar macrophages was better in patients with 
right lung tumors than in patients with malignancies of the left 
lung. The location of the tumor possibly forms an extra 
impediment for the air passage in the left lung leading to a 
lower number of alveolar cells in the sputum, which is 
understandable when the anatomy of the trachea and main bronchi 
is taken into consideration. 
The same picture emerges with tumor location in the upper, 
middle or lower lobes. Tumor location in the upper lobes is 
associated with a higher number of macrophages. When multiple 
tumor locations are compared it appears that tumors located in 
upper and middle lobes can be related to higher numbers of 
squamous epithelial cells (P<0.01) apparently because of blocking 
the air passage more completely, than in comparison with tumors 
in upper and lower lobes and with tumors with a peripheral (vs 
central) location which are associated with higher numbers of 
alveolar macrophages, bronchial columnar cells and squamous 
metaplastic cells. 
In patients with centrally located tumors, in patients with 
very large tumors and in patients producing bloody sputum the 
number of tumor cells was significantly higher. 
Epithelial metaplasia of the bronchial epithelium as 
indicated by a high number of squamous metaplastic cells was 
found in patients over 60 years of age, in patients with a low 
Vital Capacity and in patients with a low Ге ^ value. No 
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significant relation with the cellular composition of sputum was 
found in patients with previous lung disease, with a history of 
wheezing, dyspnoea and with atelectasis. 
In sputum specimens from patients with squamous cell cancer 
significantly higher number of tumor cells were found than were 
found in sputum specimens from patients with small cell 
anaplastic cancer and large cell anaplastic cancer. The lowest 
number of tumor cells was found in sputum specimens from patients 
with adenocarcinomas. In 9ЭЙ of specimens the percentage of tumor 
cells per sputum specimen was less than 10%. In 75% of sputum 
specimens this percentage was less than 2%. 
In the diagnosis of lung cancer the cellular composition of 
the sputum specimen is of utmost importance for the estimation of 
the probability of a diagnosis being correctly positive or false 
negative. The mere presence of alveolar macrophages is not 
sufficient evidence for a good quality specimen. The relative 
proportion of the alveolar macrophages, bronchial columnar cells 
and dysplastic cells is a better parameter for the reliability of 
the sputum specimen. 
In the process of evaluation patient characteristics should 
be taken into account since these have a significant influence on 
the cellular composition of the sputum and thus on the 
possibility for a correct diagnosis. 
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ABSTRACT 
In patients with a malignant lung process (146 patients with 
primary lung cancer and 21 patients with a metastatic lung 
malignancy) the quality and the percentage of correct positive 
diagnoses of sputum produced directly after bronchoscopy was 
evaluated. 
The quality of prebronchoscopic and postbronchoscopic sputum 
differ significantly, the former being of better quality for 
cytologic diagnosis. When calculated for the whole group the 
quality of postbronchoscopy sputum was not related to any 
specific anamnestic or clinical patient data. There was no 
statistically significant difference between the percentages of 
correct positive diagnoses in pre- and postbronchoscopy sputum 
specimens. 
However, the percentage of correct positive diagnoses was 
significantly higher in post-bronchoscopy sputum in comparison 
with the results of sputum cytology prior to bronchoscopy when 
the results were calculated separately for patients with low FEV^ 
values (<50% of the Vital Capacity) or for patients without a 
history of previous sputum production. In patients who produced 
bloody sputum the percentage of correct positive diagnoses in 
prebronchoscopy sputum was significantly higher than in post 
bronchoscopy sputum. 
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INTRODUCTION 
In many patients in whom a suspicion for lung cancer exists, 
bronchoscopy in the course of the diagnostic phase is carried 
out. It has been stated by several authors that the quality of 
postbronchoscopy sputum and the results of the cytologic 
examination are better than those of prebronchoscopic 
sputuml-10,14,15, However, in none of these studies were the 
quality and the diagnostic results of pre- and postbronchoscopic 
sputum compared on a patient level. In a previous study we had 
investigated the possible influence of patient characteristics 
such as age, sex, type of sputum produced, chronic lung disease, 
Vital Capacity (VC) and Forced Expiratory Volume (FeV^) on the 
quality of the sputum and on the accuracy of the cytologic 
diagnosisl2. 
The purpose of this study is to compare the quality and the 
results of the cytologic examination of prebronchoscopic and 
postbronchoscopic sputa. Furthermore, the effect of certain 
anamnestic and clinical characteristics on the quality and the 
results of the cytologic examination of postbronchoscopy sputum 
is determined. The contribution of the cytologic examination of 
postbronchoscopy sputum to the final diagnosis of a malignant 
lung process is analysed. 
MATERIALS AND METHODS 
From a total group of 476 patients with a confirmed 
malignant process of the lungs both pre- and postbronchoscopy 
sputum from 146 patients with a primary malignant lung process 
and 21 patients with a metastatic lung malignancy was submitted 
for cytologic diagnosis. In the remaining group of 309 patients 
only pre- or postbronchoscopy sputum was received. 
69 
The sputum was collected in a fixative consisting of ethanol 
50ä carbowax R 2% (polyethyleneglycol 1500, Merck-Schuchardt, 
Hohenbrunn, W-Germany). The the sputum mixture was blended and 
centrifugedla according to Saccomanno's technique. From the 
sediment a minimum of two smears was prepared. 
After air drying, the smears were postfixed in ethanol 96% and 
stained according to the Papanicolaou procedure. Post 
bronchoscopy sputum was defined as the first sputum specimen 
produced within 30 minutes after a bronchoscopy was performed. 
The number of pre bronchoscopy Sputums ranged from one to six 
specimens and the number of postbronchoscopy Sputums ranged from 
one to three specimens per patient. 
The sputum specimens were considered to be of insufficient 
quality when they were composed exclusively of squamous cells 
from the upper airways and atypical cells were absent or when the 
samples showed a predominance of necrotic material, erythrocytes 
or inflammatory cells. 
Two cytopathologists (EKJR and GPV) reviewed the cytologic 
specimens with knowledge of the definitive histologic and 
clinical findings to establish a final cytologic diagnosis. 
Anamnestic and clinical data were gathered as we reported 
earlier, by a thorough review of all clinical records!!. When 
necessary, data were retrieved from general practitioners' 
patient files as well. 
A definitive diagnosis of malignancy was established by 
histologic examination of a pulmonary lesion or of a regional 
metastasis, or on the basis of conclusive radiographical and 
clinical evidence. 
In a previous study the relation between a number of 
anamnestic and clinical patient data - so called "patient 
characteristics" - and the quality of the sputum and the 
diagnostic outcome of the sputum cytology was analysedl2. For 
this study "patient characteristics" used in the analysis of the 
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quality and diagnostic outcome of both pre- and postbronchoscopy 
sputum were: age, sex, chronic lung disease, previous sputum 
production, smoking habits, Vital Capacity, Forced Expiratory 
Volume (FeVl)i location of the tumors (central or peripheral and 
upper -, middle - or lower lobe in right- or left lung), total or 
partial stop at bronchoscopy, size of the tumor, type of sputum 
produced (bloody or non bloody) and histologic type of the tumor. 
Since the results of this study showed significant relations 
between a number of these patient characteristics and the 
diagnostic outcome of sputum, we calculated the differences in 
quality and diagnostic outcome of pre- and postbronchoscopic 
sputum on a patient basis and not on the basis of both groups of 
specimens. 
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In short, the number of sputum specimens to be examined for an 
optimal sensitivity of sputum diagnosis is not yet known. Since 
the number of tests applied to a patient varies considerably, 
calculation of sensitivity and specificity is less appropriate 
for the evaluation of sputum diagnosis. 
RESULTS 
From the whole group of patients 340 pre-bronchoscopic and 
149 post-bronchoscopic sputum specimens were obtained. From the 
pre-bronchoscopic Sputums 88.12 of the specimens were of suffi­
cient quality for cytologic diagnosis. From the 149 post-broncho­
scopic sputum specimens 81.35 were of sufficient quality. 
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When comparing the quality of pre- and postbronchoscopic 
sputa on a patient level as sufficient or insufficient for 
cytologic diagnosis, the quality of prebroncoscopic sputa was 
better by 8.5% (SE 3.89) in the 146 patients with primary lung 
cancer. This difference is significant (P<0.04). In the 21 
patients with proven metastatic malignant lung tumors, the 
quality of sputa before and after bronchoscopy showed no 
statistical significant difference: in 4.OS (SE 9.6) of the 
patients the sputum before bronchoscopy was of better quality. Of 
the total group of 146 patients with a proven primary lung 
cancer, 112 patients submitted sputum specimens before and after 
bronchoscopy of sufficient quality for cytologic diagnosis. 
In this group the difference between the percentages of correct 
positive sputum diagnoses in pre- and postbronchoscopy specimens 
was 1.5S (SE 5.3). This difference is not statistically 
significant. In 16 patients with a proven metastatic malignant 
lung proces the percentages of correct positive diagnoses in 
sputum before and after bronchoscopy differed 7.8% (SE 14.7). 
This difference is not significant. 
In the total group of 146 patients with a primary lung 
cancer, patient characteristics were not significantly related to 
the quality of both pre- and postbronchoscopy sputum. 
In patients with low Forced Expiratory Volume values (FEV¿ < 50% 
of the Vital Capacity) the percentage of correct positive sputum 
diagnoses in sputa after bronchoscopy was significantly higher 
(P<0.02) than the percentage of correct positive diagnoses in 
prebronchoscopy sputum. 
A negative history of sputum production prior to the present 
disease process was also related to a significantly higher 
percentage of correct positive diagnoses in sputa after 
bronchoscopy (P<0.04). The production of "bloody" sputa was 
related to a significantly (P<0.04) higher percentage of correct 
positive diagnoses in sputum before bronchoscopy. In patients 
producing non-bloody sputum there was no significant difference 
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between the percentages of correct positive diagnoses in sputa 
before and after bronchoscopy. 
None of the other patient characteristics showed a significant 
difference between the percentages of correct positive cytologic 
diagnoses in pre- and postbronchoscopy sputum specimens. 
Probability figures for a correct positive diagnosis using 
Kaplan-Meier estimates were calculated for series of pre­
bronchoscopy sputum specimens and pre- and postbronchoscopy 
sputum specimens combined, from the 112 patients with primary 
lung cancer (Table 1). Because of the low number of patients with 
a metastatic lung process having produced both pre- and 
postbronchoscopic sputum (N=16), calculations of probability 
figures for correct cytologic diagnoses were not done. 
Table 1: Probability of a correct positive cytologic diagnosis 
of pre- and postbronchoscopy sputum expressed as a 
function of the number of sputum specimens examined in 
patients with primary lung cancer 
Prebronchoscopy sputum Pre- and 
postbronchoscopy sputum 
Number of 
specimens 
examined 
1 
2 
3 
4 
5 
N 
Ρ 
umber 
atient 
112 
35 
15 
5 
4 
of 
8 
Probability 
of a correct 
positive 
diagnosis * 
error 
0.45 * 
0.56 * 
0.68 * 
0.74 * 
0.94 * 
0.05 
0.05 
0.06 
0.08 
0.06 
N 
Ρ 
umber 
atient 
112 
64 
28 
15 
5 
of 
.3 
Probability 
of a correct 
posit: Lve 
diagnosis ± 
error 
0.43 
0.63 
0.69 
0.80 
0.88 
A 
* 
* 
* 
* 
0.05 
0.05 
0.05 
0.05 
0.05 
In this series of patients the probability for a correct 
positive diagnosis in prebronchoscopy sputum increased from 0.45 
(SE 0.05) to 0.94 (SE 0.06) when a range of one to five sputum 
specimens was examined respectively. In comparison, probability 
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D I S C U S S I O N 
Most reports in the literature dealing with the effect of 
bronchoscopy on the accuracy of sputum cytology in the diagnosis 
of malignant lung processes speak of better quality of 
postbronchoscopy sputum, when comparing the diagnostic results of 
cytology in sputum produced prior to and after bronchoscopic 
examinationl-10>14tl5. 
In a previous study we described in detail the relation 
between certain anamnestic and clinical patient data -"patient 
characteristics"- and the diagnostic outcome of sputum 
cytologyl2. 
Since the chance for a positive sputum diagnosis is related to 
specific patient characteristics, the diagnostic accuracy of 
sputum cytology should be calculated on a patient basis and not 
as an average of the total number of specimens examined. 
Therefore we consider calculations of the accuracy of sputum 
diagnoses on a specimens level, without correcting for the 
diagnostic outcome per individual patient, incorrect and 
potentially leading to misleading conclusions. 
In the present study the quality of sputum prior to 
bronchoscopy was significantly better (P<0.04) than the quality 
of postbronchoscopy sputum when calculated on the patient 
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level. The difference in the percentages of sputum specimens 
satisfactory for cytologic diagnosis was θ.5%. 
The percentages of correct positive cytologic diagnoses in 
pre- and postbronchoscopy sputum were not significantly 
different. Therefore postbronchoscopy sputum does not make a 
greater contribution to a correct positive diagnosis of a 
malignant process than an extra sputum cytologic investigation 
prior to bronchoscopy would have given. In a previous 
communicationll we reported correct positive cytologic diagnoses 
as a function of the number of specimens examined. In this study 
probability figures for a correct positive diagnosis on a patient 
level, using Kaplan Meier estimates, were not significantly 
different when comparing series of one to five prebronchoscopic 
sputum specimens with series of both pre- and postbronchoscopic 
sputum specimens submitted in chronological order. If post 
bronchoscopic sputum specimens made a greater contribution to the 
final correct positive diagosis, these differences would have 
been statistically significant. 
Differences in the quality of the pre- and postbronchoscopy 
sputum when related to "patients characteristics" were not 
significant. However, a significant difference in the number of 
correct positive cytologic diagnoses between pre- and 
postbronchoscopy sputum was found when related to low ГЕ ^ values 
(0-50% of the Vital Capacity). Significantly better results were 
then obtained in postbronchoscopy sputum. The diagnostic outcome 
of postbronchoscopy sputum was also significantly better in 
patients without a history of sputum production prior to the 
present disease process. In patients who produced bloody sputum 
the percentage of correct positive diagnoses in prebronchoscopy 
sputum was significantly higher. 
There is disagreement between our conclusion that 
bronchoscopy as such does not improve the percentage of correct 
positive diagnoses in sputum cytology and the data reported in 
the literature. This might be explained by the fact that in our 
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study the quality and the diagnostic outcome of pre- and 
postbronchoscopic sputa were not calculated on a specimen level, 
but on a patient level. 
In other studies patient characteristics have not been taken 
into account. The differences in the quality and the diagnostic 
outcome of the two sputum types in those studies are likely to be 
caused by patient related data and not by the effect of 
bronchoscopy . 
In a previous studyll we calculated a probability of 0.90 
for a correct positive sputum diagnosis in patients with primary 
lung cancer when a series of 5 sputum specimens was examined. 
Since most patients produce sputum specimens shortly after 
bronchoscopy this additional sputum specimen may well be used to 
complete such a series and thus obtain a positive diagnosis in 
patients suspicious for a malignant lung proces. 
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A B S T R A C T 
From 421 patients with a malignant lungprocess (primary or 
metastatic) a sputum cytologic diagnosis of severe dysplasia was 
made in 46 patients. In 25 patients with severe dysplastic cells 
in their sputum at follow up no malignant lungprocess was 
diagnosed. 
In 21 patients at follow up of sputum diagnosis consistent with 
severe dysplasia, a malignant process became evident. 
Both patient groups were compared to patients with correct 
negative and correct positive sputum diagnoses. Patient charac-
teristics such as age, previous sputum production, Vital 
Capacity, low Forced Expiratory Volume were not significantly 
related to sputum findings consistent with severe dysplasia with 
or without an underlying malignant lung process. Particularly 
severe dyspnoea showed a significantly higher frequency in sputum 
cytologic diagnosis consistent with dysplasia without an under-
lying malignant lung process. 
The presence of severly dysplastic cells in sputum specimens from 
patients without signs of severe dyspnoea and or chronic cough 
together with complaints of previous lung disorders should be 
considered a warning signal for an underlying malignant lung 
process. At follow up in 46% of these patients a malignant lung 
tumor was found. Since severe dysplasia should be considered a 
premallgnant epithelial lesion in patients with sputum diagnosis 
of severe dysplasia it may be advisable to take multiple brush 
cytologic specimens from all suspected epithelial lesions at 
bronchoscopy together with segmental bronchial washings. In case 
a malignant process can not be localized, sputum examinations 
should be made at three month intervals. 
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INTRODUCTION 
The increasing acceptance of the Saccomanno method for 
sputum cytology in the diagnosis of lung cancer results in 
severely dysplastic cells being found several times in a year in 
a cytology laboratory. As yet, no established opinion exists 
regarding the diagnostic significance of dysplastic cells in the 
search for malignant lung processes. 
In the literature there are only a few reports on sputum 
cytologic diagnosis of precancerous lung lesions or early 
invasive squamous cell carcinomas. 
Saccomanno investigated the development of lung cancer in 
more than 5,000 uranium miners using sputum cytology'-H. 
Contrary to direct smears and paraffin embedded sputum, 
Saccomanno blended the sputum and made smears from the sediment 
of the homogenised specimen^. In 38 uranium miners an invasive 
squamous cell cancer developed. In 22 of these patients (60%) at 
cytologic examination atypical cells consistent with severe 
dysplasia were diagnosed. At follow up invasive squamous cell 
cancers became evident. 
Woolner described sputum results in 28 patients with in situ 
and early invasive bronchogenic carcinoma^'· in that study a 
sensitivity of 78% was reached. Erozan analysed quantitatively 
the difference between cells in sputum from in situ and invasive 
squamous cell cancer cells. It was reported that severe 
dysplastic cells were significantly more frequent in cases of 
invasive carcinoma than in the group with in situ squamous cell 
cancer^· Tao studied 20 patients with radiographically occult 
squamous cell carcinoma all diagnosed with sputum cytology!?. j n 
5 patients (255·) an in situ squamous cell carcinoma was found, 
the remaining 15 patients showed evidence of invasive squamous 
cell carcinoma. Nasiell describes sputum cytology in 516 patients 
without lung cancer and found in 3% of these patients severe 
dysplastic cells4. In 6% of 33 patients with adenocarcinoma 
severe dysplastic cells were also found. In 137 patients with 
squamous and undifferentiated carcinoma in 11% of patients severe 
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dysplasia was diagnosed in the sputum. The same author examined 
the DNA content of dysplastic and squamous cancer cells^. From 
this study it may be concluded that bronchial squamous carcinoma 
is preceded by sequential changes in the bronchial epithelium. 
In previous papers we reported on the diagnostic accuracy of 
sputum cytology according to the Saccomanno method^ and on the 
relation between a number of "patient characteristics" and the 
accuracy of sputumcytologic diagnosis^ in patients with lung 
cancer. 
The aim of the present study is to assess the diagnostic 
significance (predictive value) of the presence of abnormal cells 
consistent with a severe dysplasia in sputum in patients 
suspected of primary or metastatic malignant lung processes. 
Furthermore the relation between the presence of severe 
dysplastic cells in sputum and anamnestic and clinical 
characteristics of these patients will be analysed. 
MATERIALS AND METHODS 
Patients in this study originated from the sputum cytology 
registration in the Laboratory of Cytopathology of the Radboud 
University Hospital in the period January 1974 through September 
1980. Only patients with three or more sputum specimens, 
satisfactory for cytologic diagnosis, were considered. From the 
resulting series of diagnoses for each patient the highest 
diagnosis with respect to lung malignancy was used as the final 
cytologic diagnosis in the analyses. A definitive diagnosis of 
lung malignancy was established by histologic examination, 
conclusive radiographical and clinical evidence^ or the clinical 
absence of malignancy after a follow-up of 2-8 years. 
The patients considered in this study were subdivided into 
three categories. The first category comprised a total of 421 
patients with a proven malignancy i.e. 318 patients with a 
primary lung cancer and 103 patients showing a metastatic 
pulmonary malignancy. The second category consisted of 25 
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patients with a sputum diagnosis consistent with severe dysplasia 
but without a malignant lung process at follow up. The third 
category was a randomly chosen sample of 52 patients from a 
large group of patients with a correctly negative sputum 
diagnosis. 
Sputum specimens were collected in a fixative consisting of 
ethanol 50S, carbowax R 2% (polyethyleneglycol 1500, 
Merck-Schuchardt, Hohenbrunn, W. Germany). The sputum mixture was 
blended and centrifuged according to Saccomanno's technique^. 
From the sediment a minimum of two smears was prepared. After air 
drying, these were postfixed in ethanol 96% and stained according 
to the Papanicolaou procedure. 
Sputum specimens were considered to be of insufficient quality 
for cytologic diagnosis when they consisted exclusively of 
squamous cells from the upper airways in the absence of atypical 
cells, or when the samples consisted mainly of necrotic material, 
erythrocytes or inflammatory cells. 
All sputum specimens were reviewed by two cytopathologiats 
(EK3R and GPV) who had previous knowledge of all pertinent 
clinical findings and of the final histologic diagnosis. 
From the total group of patients entered in the registry, on 
basis of sputum diagnosis the following groups were selected: 
A - "consistent with severe dysplasia" in patients without a 
malignant lung process at follow up. ("dysplasie-correct"; 
N=25). 
В - "negative" for malignancy in patients without a malignant 
lung process at follow up ("correct negative"; №52). 
С - "consistent with severe dysplasia" in patients with a 
proven primary malignancy of the lung at follow up. 
("dysplasia-underestimated"; N=21). 
D - "malignant cells present" in patients with a primary 
malignancy ("correct positive"; N=202). 
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As we reported earlier6,7t there was a thorough review of 
all clinical records to gather anamnestic and clinical data 
("patient chacteristics"). In some patients data were also 
retrieved from general practitioners data files. Patient 
characteristics analysed for their influence on the presence of 
severe dysplastic cells in sputum were: sex, age, previous 
pulmonary disease, recent lung complaints, tingling cough, 
chronic cough, previous sputum production and aspect of sputum, 
dyspnoea, wheezing, and lung function test-results such as Vital 
Capacity and Forced Expiratory Volume (FEVi). 
To determine whether a combination of previous or chronic 
lung problems had any relation to the accuracy of sputum 
diagnosis an analysis was made, relating this characteristic of 
"chronic pulmonary disease" to sputum diagnosis combining into 
one group those patients who had two or more of the following 
characteristics "previous pulmonary disease", "wheezing", 
"dyspnoea", "chronic cough" and "tingling cough". 
Since in a relatively large number of patients one or more lung 
function tests (Vital Capacity and Forced Expiratory Volume) were 
missing and the results of these tests when related to the 
previous characteristics did not enforce "the profile of chronic 
pulmonary disease", these characteristics were left out. 
The group of patients in this study was chosen in such a way 
that two questions might be answered (Table 2). 
The first question concerns the significance of patient 
characteristics in relation to in the format of two explorative 
case control studies^. In the first case-control study cases were 
25 patients at follow up without a malignant lung process, having 
sputum diagnoses of severe dysplasia (group A). As controls 52 
correctly negative patients (group B) were chosen. This 
comparison allowed the detection of possible risk factors for 
severe dysplasia as an imminent illness. The second case-control 
study compared 202 patients with correctly positive malignant 
diagnoses (part of group D) as clear cases with 25 patients with 
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correct sputum diagnoses of "severe dysplasia" (group A) as 
controls, to gain more insight into the differential diagnosis of 
pathologic lung processes. 
The second question was of a more practical nature, including 
tuning of the sputum diagnosis "severe dysplasia". What 
differences existed between patients with correct sputum 
diagnoses "severe dysplasia" and incorrect sputum diagnoses of 
"severe dysplasia" ("dysplasia underestimated"). In this part of 
the study 25 patients from group A were compared to 21 patients 
from group C. 
A possible confounder in these comparisons could be the 
nature of the malignant process, primary or metastatic. Since 
patients having a correct diagnosis of "severe dysplasia" were 
generally not suspected of a metastatic lung tumor, initial 
analyses were restricted to patients with a primary lung tumor 
(group D). 
These four subgroups in the study were tested simultaneously 
with respect to the different patient characteristics using the 
chisquare-test. If such a chisquare-test did not give a 
significant result that particular characteristic was not 
considered in further explorative analyses. In case of an 
"overall" significant patient characteristic three 
chisquare-tests were done in concordance with the three questions 
of the study. 
RESULTS 
Analysis of patient characteristics in the four groups of 
patients showed no significant relations with the following 
patient characteristics, age, previous sputum production, aspect 
of sputum, wheezing, Vital Capacity and Forced Expiratory Volume. 
Patient characteristics showing "overall" significant differences 
between the four different patient groups are summarized in table 
1. Further test results are given in table 2. 
85 
Table 1: Significant relationships between patient characteristics and 
accuracy of sputum diagnosis. Patients characteristics are given 
in percentages for each subclass of sputum diagnosis. 
Patients 
characteristics 
Sex: female 
Tingling cough 
Dyspnoea moderate 
Dyspnoea severe 
Chronic cough and 
Previous pulmonary 
diseases 
Total N = 
No lung 
Severe 
dysplasia 
correct 
% 
20.0 
23.θ 
21.7 
39.1 
86.9 
52 
cancer 
Correct 
negative 
% 
21.2 
6.0 
23.5 
23.5 
69.1 
25 
Primary 
Severe 
lung cancer 
dysplasia 
under­
estimated 
% 
4.8 
10.0 
30.0 
5.0 
52.9 
21 
Correct 
positive 
% 
5.9 
23.3 
44.8 
6.2 
76.4 
202 
P-
value 
0.002 
0.03 
0.001 
0.0001 
0.05 
In the correct severe dysplasia group and in the correct 
negative group the proportion of women was significantly higher 
(p=0.002). In view of the higher proportion of men among patients 
with primary lung cancer this finding gains in relevance. 
Patients with tingling cough were more frequent with correct 
sputum diagnoses: "severe dysplasia" and "positive for lung can­
cer" (p=0.04). Patients with moderate dyspnoea were significantly 
less represented in patients with correct diagnoses of dysplasia, 
whereas patients with severe dyspnoea were significantly more 
frequent in the group of patients with correct sputum diagnoses 
of severe dysplasia (psO.0001). The proportion of patients with a 
history of chronic cough and previous multiple complaints of 
pulmonary disease is highest among patients with a sputum 
diagnosis consistent with dysplasia but without a lung tumor at 
follow up (p=0.05). 
Analysis made for significant relations with patient charac­
teristics between patients with correct sputum diagnoses of 
severe dysplasia and each of the three remaining subgroups 
separately (table 2) showed no significant differences with the 
group of patients with correct negative sputum diagnoses, with 
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Table 2: Significant differences in patient characterisitics 
between patients with correct sputum diagnoses 
consistent with severe dysplasia (N=25) compared to 
patients with sputum diagnoses "correct negative", 
severe dysplasia underestimated and "correct positive" 
(p values for patient characteristics) 
No lung cancer Primary lung cancer 
Patients 
characteristics Correct Severe dysplasia Correct 
negative underestimated positive 
Sex female - - 0.01 
Tingling cough 0.03 
Dyspnoea severe - 0.03 0.0001 
Wheezing - 0.05 
Chronic cough and 
previous pulmonary - 0.02 
disease 
Total number 
of patients N=52 21 202 
not significant 
the exception of tingling cough being more frequent in the group 
of patients with severe dysplasia (p=0.03). 
In comparison with the group of patients with sputum 
diagnoses of severe dysplasia underestimated (lung cancer at 
follow up) in the group of patients with correct sputum diagnoses 
of severe dysplasia, wheezing, chronic cough and multiple 
previous lung complaints were significantly more frequent. 
In comparison with the group of patients with correct positive 
sputum diagnoses in the group of patients with correct sputum 
diagnoses of severe dysplasia female patients were significantly 
more frequently present (p=0.01). 
When the groups of patients were enlarged with those patients 
proven to have metastatic disease (N=103) none of the patient 
characteristics which were significantly related to one of the 
four sputum diagnoses in patients with and without primary lung 
cancer showed a different pattern although minor changes in 
P-values were observed. 
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DISCUSSION 
A sputum cytologie diagnosis of severe dysplasia often poses 
a problem to the clinician since a malignant lung process has to 
be excluded. As follow up procedures in these patients are 
usually very extensive and time consuming, all additional 
information which may help to determine the correct final 
diagnosis should be used in the decision process. In our series 
in 46% of patients with a sputum diagnosis consistent with severe 
dysplasia, at follow up a malignant tumor was proven to be 
present. 
Significantly related to correct sputum diagnosis of severe 
dysplasia were sex, tingling cough, severe dyspnoea, wheezing and 
a history of chronic cough and multiple complaints indicating 
previous pulmonary disorders. 
In patients with these characteristics at follow up a 
relatively high proportion proved to be free of a malignant lung 
process, even though severly dysplastlc cells were found. From 
the present and previous analyses of our patient group the 
picture emerges that in patients with lung cancer the proportion 
of patients with known previous pulmonary disease is not 
significantly higher than in our control group of patients known 
to be free of malignant disease. In patients with false negative 
sputum diagnoses the proportion of patients with known previous 
pulmonary disease was lower than in all patient groups used in 
our analyses. 
In patients with sputum diagnoses of severe dysplasia but 
with proven malignancies at follow up the relative proportion of 
patients without chronic pulmonary complaints was highest. The 
absence of these characteristics indicating such pulmonary 
problems should be considered a warning signal for an underlying 
malignant tumor. In these patients it may be advisable to take 
multiple brush cytologic specimens from all suspected epithelial 
changes together with segmental bronchial washings. These results 
conflict with the general opinion that the probability of lung 
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cancer is highest in patients with chronic lung disorders^,7. 
Further studies are required to clarify this point. 
However, since severe dysplasia should be considered a 
premalignant epithelial lesion and since the progression time 
into an invasive cancer is not known, in patients with sputum 
diagnosis of severe dysplasia in whom a lung malignancy or an 
upper airway cancer can not be localized, a sputum examination 
every three months is advisable. In cases of inflammation 
severely dysplastic cells can disappear after treating the 
inflammatory process. Dysplasia may also decrease in heavy 
smoking patients, after they stop smoking. When patients with 
metastatic malignancies were included in the analyses the pattern 
of relations between these selected patients characteristics and 
categories of sputum diagnoses did not change. 
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CHAPTER 6 
THE CYTOPATHOLOGY OF SPUTUM IN DIAGNOSING BENIGN, 
PRE-HALIGNANT AND MALIGNANT LUNGPROCESSES 
WITH SPECIAL REFERENCE TO DIFFERENTIAL DIAGNOSTIC PROBLEMS 
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Sputum contains several celltypes. From the upper airways 
squanous epithelial cells are exfoliated. They seldom pose a 
differential diagnostic problem in differentiating from squamous 
cell cancer cells. They can cause some problems when there is 
atypia, as is the case in patients treated with radiation of the 
upper airways. In these cases clinical information is essential. 
Contaminants from the upper airways are bacteria, fungi 
(candida albicans, Alternarla) and actinomyces. Also 
polymorphonuclear leukocytes found in sputum specimens originate 
in most cases from there. 
For the inexperienced, contamination with vegetable cells (mostly 
food) can cause a problem in differentiating these from malignant 
cells. The presence of cellulose cellwalls and cytoplasmic 
granulations should be the clue to the vegetable origin of these 
cells. 
Beneath the vocal cords the lining of the respiratory tract 
is of columnar cell type. Columnar cells are partly of mucus 
producing, partly of ciliated type. In profile they are 
characterized by a columnar or prismatic shape with exentrically 
located nuclei often ending in a tail. On transverse section they 
have a honeycomb appearance. Less frequently, columnar cells ere 
exfoliated from the upper airways in sputum. 
Diagnostic difficulties may arise in the differentiation 
between transversed columnar cells and small cell cancer cells 
(fig. 1). When cilia are present the diagnosis of benign cells is 
easy, but sometimes cells are degenerated and cilia are lost. 
Then the presence of a terminal plate is helpful for a correct 
diagnosis. These degenerated cells can show moulding which causes 
differential problems with small cell cancer. However the mere 
presence of moulding without pleomorphism and an irregular 
distribution of nuclear chromatin is not sufficient evidence for 
malignancy and the possibility of degenerated columnar cells 
should be considered. 
Another differential diagnostic problem is caused by 
papillary clusters of hyperplastic columnar cells which can mimic 
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cells from a highly differentiated adenocarcinoma (fig. 2). 
Usually ciliated cells are recognizable which indicates benign 
hyperplasia. Also a finely granular chromatin pattern and 
uniformity and regularity in size and shape of nucleoli are very 
helpful keys to the benignancy of these papillary clusters of 
hyperplastic columnar cells. Hyperplasia may occur in response to 
a number of chronic diseases of the lung, particularly 
bronchiectasis, chronic bronchitis and asthma. 
Cells exfoliated from terainal bronchioles and from alveolar 
walls are seldom found in sputum. 
Usually these cells are not recognized in sputum when present in 
an unaltered form, because they are mistaken for alveolar 
macrophages. They are relatively small rounded single cells with 
a centrally placed nucleus and finely vacuolated cytoplasm. 
Differential diagnosis with singly lying tumorcells from large 
cell carcinomas sometimes can cause problems, but a high nuclear 
cytoplasmic ratio in the latter helps to distinguish malignant 
cells from reactive onea. 
When enlargement of bronchiolo alveolar cells occurs in the 
presence of injuries, especially pulmonary infarcts, differential 
diagnosis may become difficult. Cells are desquamated as small 
papillary tissue fragments, composed of cells with enlarged 
centrally placed nuclei and one or more nucleoli. The cytoplasm 
may be granular or vacuolated. Then differential diagnosis 
between benign reactive cells and cells from bronchioalveolar 
cell carcinoma is a problem. Variation of cytomorphology in these 
reactive cell clusters is a diagnostic feature suggestive of 
benignancy. 
The presence of pulmonary alveolar •acrophages usually does 
not cause a differential diagnostic problem. Characteristic 
features are an eccentric position of the nucleus and an abundant 
foamy cytoplasm which contains phagocytized material, usually 
dust particles. Nucleoli may be present. Some of these cells can 
яіяіс cells fro· a poorly differentiated adenocarcinona. Then the 
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presence of phagocytized material in the cytoplasm is helpfull in 
diagnosing these cells as benign. 
Other cells which can cause differential diagnostic problems 
are lyafocytes, since these can Mimic aaall cell anaplastic 
carcinoma cells. Lymfocytes can be distinguished by failing to 
mould to one another and by lacking malignant criteria such as 
cellular pleomorphism and irregularity of nuclear chromatin 
patterns as characteristically present in small cell cancer 
eel Is. 
Rather frequently, columnar cells have been transformed 
into squamous •etaplastic cells, particularly in cigarette 
smokers. Squamous metaplastic cells may be seen as single lying 
cells and as small tissue fragments, which have a uniform 
monolayered arrangement (fig. 3). They resemble mature squamous 
cells, but they are smaller and possess a higher 
nucleo/суtoplasmic ratio. Nuclei have a regular chromatin pattern 
and small nucleoli may be present. The cytoplasm can be 
vacuolated and is sharply demarcated. 
I. EPITHELIAL TUMORS 
A. BENIGN 
1. Papilloeas 
a. Squamous cell papilloma. These tumors are covered by 
stratified squamous epithelium, occasionally mixed with 
mucus producing cells. This type of tumor may show 
dysplasia in older patients, but is otherwise not 
recognizable in sputum. 
b. "Transitional" papilloma. In these tumors areas of 
cuboidal, columnar and ciliated epithelium may be 
present. Also foci of squamous differentation and 
mucus secretion may be present. This type of tumor may 
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show dysplasia or malignant transformation into 
"transitional" carcinoma but is otherwise not 
recognizable in sputum. 
Adenoaas 
a. Pleomorphic adenoma ("mixed" tumor). A benign tumor of 
salivary gland type characterized by a mixed appearance 
of epithelial tissue and tissue of myxoid appearance. 
Although arising in larger bronchi, cells shed from 
these tumors are not recognized in sputum. 
b. Monomorphic adenoma. They are similar to the adenomas of 
the monomorphic type of the salivary gland. Cells from 
these tumors are not recognizable in sputum. 
DYSPLASIA AND CARCINOMA IN SITU 
When squamous metaplastic cells show pleomorphism this is 
called atypical squamous metaplasia (fig. 4). Occasionally 
this is accompanied by nuclear abnormalities of increasing 
degrees of severity, an increase of the nucleo/cytoplasmic 
ratio and hyperchromasla. These cells are called dyspleatlc 
(mild fig. 5, moderate fig. 6 or severe fig. 7) and in 
contrast to dysplasia of the uterine cervix may contain 
nucleoli. Squamous metaplasia up to and including severe 
dysplasia can be reversible, but may progress to squamous cell 
cancer. Severe dysplasia is often present in patients with 
lung malignancies. Particularly when chronic lung complaints 
are absent a thorough check-up of these patients is 
recommended. When a lung malignancy or an upper airway cancer 
can not be localised a sputum examination every three months 
is advisable. In cases of inflammation severely dysplastic 
cells can disappear after treating the inflammatory process. 
Dysplasia may also decrease in heavy smoking patients, after 
they stop smoking. 
97 
The cytologic picture of carcinoma in situ of the lung is 
essentially the same as that of invasive squamous carcinoma. 
However in the presence of an inflammatory background (tumor 
diathesis) or of many bizarre cells it is unlikely, that the 
process is still in situ. Also, cells derived from carcinoma 
in situ are mostly single and not paired or in a sheet like 
arrangement as is seen in invasive squamous cancer. 
MALIGNANT 
1. Squamous cell carcinoma is made up of well defined tumor 
cells, often lying in sheets. 
a. Well differentiated keratinizing squamous cell cancer is 
characterized by tadpole cells (fig. 8) and fiber cells 
(fig. 9) with orangeophilic cytoplasm in which keratin 
fibrils can be recognized. The chromatin is dense and in 
well-preserved cells distributed in irregular clumps. As 
a rule nucleoli are absent. Further there may be 
malignant keratin pearl formation (fig. 10). The 
background may or may not exhibit a granular necrotic 
quality (tumor diathesis) (fig. 11). 
b. Moderately differentiated and 
c. Poorly differentiated non keratinizing squamous cell 
cancer cells have a cyanophilic cytoplasm, that has the 
same dense quality as that of the keratinized malignant 
tumor cells (fig. 12). The nuclear structure is the same 
as in the keratinizing type, but some nucleoli may be 
visible. Because of the presence of nucleoli a 
differential diagnostic problem with adenocarcinoma may 
occur, but the accentuation of the cytoplasmic membrane 
(double cell border) is a useful feature for identifying 
squamous tumor cell type. 
For differential diagnostic problems with squamous 
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epithelial cells, contaminants, dysplastic cells, 
carcinoma in situ and large cell cancer, see under these 
headings. A variant of squamous cell carcinoma is 
spindle cell (squamous) carcinoma. This tumor is 
composed of squamous cell carcinoma and a spindle cell 
component with a sarcoma-like appearance. This tumortype 
should not be confused with carcinosarcoma. 
Saall cell carcinoma. 
This tumortype is characterized by loose clusters of small 
malignant cells (fig. 13). Nuclei are markedly hyper-
chromatic, average about one and one-half times the 
diameter of lymphocytes, are very irregular in outline and 
contain clumps of irregular chromatin and occasionally a 
nucleolus. Many tumorcells are devoid of cytoplasm. A small 
rim of cyanophillc cytoplasm may be recognizable. There is 
moulding of the nuclei (fig. 14). In contrast with the WHO-
classification of 1981 cytologically no subclassification 
is possible into oatcelltype or intermediate cell type. 
Cytologic features which enable differential diagnosis with 
columnar cells and lymphocytes have already been discussed 
(page 94 and 96). 
Diagnostic difficulties between small cell cancer cells and 
other types of malignant processes may appear when a 
malignant lymphoma is present in the lung. These cells may 
be small and pleomorphic. Sometimes there is a suggestion 
of nuclear moulding. The correct diagnosis of malignant 
lymphoma depends on the clinical findings and the presence 
of single cells with a morphology of malignant lymphocytes. 
Besides this the malignant lymphoma cells are larger than 
most small cell cancer cells and show much less variation 
in size than can be seen in the latter cells. 
Also differentiation between small cell cancer and 
carcinoid tumor can cause problems. The tumorcells of the 
latter have a three dimensional configuration, show a 
remarkable uniformity with granularity of the nuclear 
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chromatin and the presence of a nucleolus in nearly every 
cell. 
Differential diagnostic problems with other types of lung 
cancer may rise particularly with poorly differentiated 
tumors. 
The size of the tumorcells and the presence or absence of 
nuclear moulding are the main features for a correct 
diagnosis. 
3. Adenocarcinoma. 
Adenocarcinoma is made up of ill-defined tumorcells, that 
often show three dimensional clustering. 
Three types of adenocarcinoma may be recognised: 
a. Acinar adenocarcinoma, sheds fewer tumorcells than 
terminal bronchiolo alveolar cell carcinmoma. Prominent 
nucleoli are present with irregular clumping of the 
chromatin. The nucleo/суtoplasmic ratio is high. 
Syncytia are formed with loss of polarity of the 
individual nuclei (fig. 15). For differential diagnosis 
with hyperplastic columnar cells (well differentiated 
adenocarcinoma) alveolar macrophages (poorly 
differentiated adenocarcinoma) and with large cell 
carcinoma see under the respective headings. 
b. Papillary adenocarcinoma has many similarities with the 
cytologic morphology of terminal bronchiolo-alveolar 
cell carcinoma (fig. 16). The nuclei are more hyper-
chromatic than in the latter and the nucleoli are larger 
with less symmetry. Differential diagnosis with 
hyperplasia of columnar cells may be difficult. 
c. Terminal bronchiolo-alveolar cell carcinoma, is charac­
terized by large numbers of tumorcells, both singly and 
in groups with excellent preservation of the tumor-cell 
morphology and retention of the individual shape of the 
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neoplastic cells (fig. 17). 
Tumor cells may appear to have cilia. However, no true 
cilia are present because there is no terminal plate. 
This "ciliated" or fuzzy border is caused by giant 
microvilli as is shown by transmission and scanning 
electron microscopy. Tumorcells are usually symmetrical 
and contain monomorphic nucleoli. Nuclear structure is 
distinct. For differential diagnosis with hyperplasia of 
columnar cells and cells from terminal bronchioles and 
alveolar walls see under these headings. 
d. Solid carcinoma with mucus formation. This type of tumor 
is cytologically not discernable from large cell 
carcinoma. 
Large cell сагсіпояа. 
This tumortype is composed of large tumor cells with little 
or no cohesiveness (fig. IB). There is marked irregular 
chromatin distribution, prominent nucleoli and a high 
nucleo/суtoplasmic ratio. The cytoplasm is often finely 
vacuolated with indistinct cytoplasmic borders. 
Differential diagnosis with reactive alveolar pneumocytes 
may be difficult. 
Also the decision whether a tumor is a poorly 
differentiated squamous cell cancer, an adenocarcinoma or a 
large cell carcinoma may sometimes be difficult. In absence 
of specific characteristics of squamous cell cancer or 
adenocarcinoma a diagnosis of large cell cancer will be 
made. A misclassification of adenocarcinoma may occur when 
tumorcells cluster and have prominent lobulated nuclei. 
Poorly differentiated squamous cell carcinoma may be 
suggested when tumorcells appear in broad sheets with 
apparently sharp cell borders. 
Two variants of large cell carcinoma may be recognized. 
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a. Giant cell carcinoma. A large cell carcinoma containing 
a prominent component of t-ighly pleomorphic 
multinucleated cells (fig 19,- In differential 
diagnosis squamous cell carcinoma nd adenocarcinoma 
with giant cells must be considered. 
b. Clear cell carcinoma. A large cell caicinoma composed of 
cells with clear or foamy cytoplasm. In differential 
diagnosis adenocarcinoma and squamous cell carcinoma 
with clear cells must be considered as well as renal 
cell carcinoma. 
5. Adenosquanous сагсіпояа. 
A carcinoma showing both squamous carcinomatous and adeno­
carcinoma tous components. 
6. Carcinoid tumor. 
This tumor type does not shed cells in sputum at an early 
stage, since it is covered by normal bronchial mucosa. With 
increasing size, it may break through the normal mucosa and 
then becomes recognizable in sputum. Carcinoid cells often 
appear as single cells, but small clusters may be found 
(fig. 20). Nuclei vary slightly in size and shape with the 
nuclear substance varying from finely vesicular to coarsely 
granular. The nuclear membrane is smooth and one or two 
prominent nucleoli are present. The cytoplasm is 
cyanophilic. Differential diagnostic problems can occur 
with lymphocytes. Carcinoid cells are larger than 
lymphocytes and have more abundant and frothy cytoplasm. 
Carcinoid cells can be distinguished from histiocytes by 
their lack of phagocytic function, and from small cell 
carcinoma cells on basis of the amount of chromatin. 
7. Bronchial gland carcinona 
a. Adenoid cystic carcinoma. This tumor is usually covered 
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by bronchial mucosa and therefore tumorcells will be 
seldom found in sputum specimens. When present, clusters 
of small tumorcells are found which possess prominent 
nucleoli. Cellular atypia usually is minimal. 
b. Mucoepidermoid carcinoma. This rare tumor sheds cells 
resembling adenocarcinoma and atypical squamous 
metaplasia or squamous cell carcinoma. Nuclear chromatin 
of both celltypes is increased in quantity and is finely 
to coarsely granular. There is little atypia. It is 
difficult to diagnose mucoepidermoid carcinoma on the 
basis of cytologic criteria alone. 
с Others. Malignant "mixed" tumors. Other malignant 
salivary gland tumors can arise from bronchial glands. 
Cells shed from these tumors are not described in 
sputum. 
Others. 
Very few basal cell carcinomas have been reported 
histologically, and cells shed from them in sputum cytology 
are as yet not described. "Transitional" cell carcinomas 
have been published as malignant degeneration of 
"transitional papilloma". The cytologic picture in sputum 
is not known. 
II. SOFT TISSUE TUMORS 
Benign soft tissue tumors arising in the lungs such as lipoma, 
fibroma, neurofibroma, lymphangioma, haemangioma, leiomyoma, 
granular cell tumor (myoblastoma) and chondroma are not 
recognizable with any accuracy in sputum. Among malignant 
tumors the following sarcoaas of the lung have been reported: 
fibrosarcoma (fig. 21), leiomyosarcoma, rhabdomyosarcoma, 
myxoliposarcoma, chondrosarcoma and angiosarcoma. Usually it 
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is not possible to make a specific diagnosis from cytologic 
specimens. The presence of spindle-shaped atypical cells 
favours a diagnosis of sarcoma, but differential 
diagnosis with carcinosarcoma and spindle cell (squamous) 
carcinoma is a problem. 
III. MESOTHELIAL TUMORS 
These tumors originate from t 
seldom sheds cells in sputum. 
clusters or singly, showing 
and the characteristic aspect 
IV. MISCELLANEOUS TUMORS 
A. Benign 
Clear cell (sugar) tumor, paragangliomas (chemodectomas) 
and teratomas are not recognizable in sputum. 
6. Malignant 
1. Carcinosarcoma. 
This extremely rare tumor is composed of a mixture of 
epithelial carcinoma and sarcomatous stroma. In general 
cancer cells from the epithelial carcinomatous component 
are recognized. A definitive diagnosis can therefore seldom 
be reached on basis of cytologic findings alone. 
2. Pulmonary blastoma. 
This rare tumor consist histologically of branching tubules 
or glands lined by a single layer of low columnar cells and 
immature mesenchymal cells, in which cart ilagenous and 
osseous differentiation is seen. Cytologically it is 
he pleura. Malignant mesothelioma 
When present, cells are lying in 
a high nucleo/суtoplasmic ratio 
of mesothelial cells. 
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characterized by coexistence of fibroblest-like spindle 
nuclei with a delicate nuclear membrane and glandular 
epithelial cells. Tumor cells are rarely encountered in 
sputum specimens· 
3. Malignant melanoma. 
Melanomas very rarely occur as primary tumors of the 
Tumors may be pigmented or non-pigmented and shed 
cells with large nuclei. Nucleoli are mostly promi 
The cells are often lying singly but clusters may be 
If melanin is present this pigment has a yellowish 
which aids in the differential diagnosis with aty 
histiocytes. 
4. Malignant lymphomas. 
It is difficult to diagnose a speci 
lymphoma from sputum. Differential 
cell cancer may be necessary. Malig 
show nuclear moulding and variety in 
in small cell cancer. 
5. Others. 
Intravascular sclerosing bronchiolo-alveolar tumors are not 
recognizable in sputum. 
SECONDARY TUMORS 
The cytologic patterns of the majority of metastatic lung 
malignancies are relatively non-specific and differential 
diagnosis with primary lung cancers on cytology alone is 
impossible. Some types of tumor cells are specific for 
metastatic processes. 
Some breast cancers metastatic to the lung have a characteris-
tic "Indian file" arrangement, but most breast cancers have 
rather unspecific features and then reseable terminal 
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bronchiolo-alveolar cell carcinoma (fig. 22). With patients in 
the last group clinical history and radiographical findings 
will lead to a correct diagnosis. Metastases of Grawitz-tumors 
may also show a characteristic cytologic picture of cells with 
prominent cell borders with clear cytoplasm and large nuclei 
with macronucleoli (fig. 23). Differential diagnosis with 
primary clear cell carcinoma must be considered. 
Cytologic features of metastases of colonic cancer can be 
rather specific in highly differentiated tumors (fig. 24). 
Tumorcells will then be arranged in multilayered clusters of 
cells of elongated columnar type. Differential diagnosis with 
terminal bronchiolo-alveolar cell carcinoma can be difficult. 
Signet-ring cancer cells are indicative of an adenocarcinoma 
originating in the digestive tract. 
When pigmentated tumor cells are present the possibility of 
metastatic malignant melanoma should always be considered. 
The presence of Reed Sternberg cells is further a specific 
feature of Hodgkin's disease (fig. 25). 
VI. UNCLASSIFIED TUMORS 
These benign and malignant tumors can not 
the above listed categories, neither 
cytologically. 
VII. TUMOR-LIKE LESIONS 
A. Hanartoma 
This tumor seldom sheds cells in sputum. 
cells with minimal atypia can be found (f 
diagnostic problems with small cell canee 
of marked pleomorphism in the former a 
coarse chromatin nuclear pattern are 
be placed in any of 
histologically nor 
Clusters of columnar 
ig. 26). Differential 
r can occur. The lack 
nd the absence of a 
indicative for the 
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diagnosis hamartoma. In both types of tumor cells moulding can 
be present. A distinction between chondromatous or 
leiomyomatous hamartoma is not possible cytologically. 
Other tumor-like lesions, such as lymphoproliferative lesions, 
tumorlet, eosinophilic granuloma, sclerosing haemangioma and 
inflammatory pseudotumor are not recognizable in sputum-
cytology. 
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1. Transversed columnar cells. Note the nuclear moulding. There is 
however no pleomorphism or irregular chromatin pattern as in small 
cell cancer. Papanicolaou stain, X 1400. 
• 
Hyperplastic columnar cells. When no cilia are recognizable, the 
finely granular chromatin pattern and the uniformity and regularity 
in size and shape of nucleoli are signs of benignancy. Papanicolaou 
stain, X 1400. 
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Fig. 3. Squamous metaplasia. A monolayer of small cells. There is a 
resemblance with squamous cells, but the nucleo/cytoplasmic ratio's 
are too great. Papanicolaou stain, X 1400. 
Fig. 4. Atypical squamous metaplasia. In this monolayer of squamous 
metaplastic cells pleomorphism is present, but no hyperchromasia is 
found. Papanicolaou stain, X 1400. 
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Fig. 5. Mild dysplasia. In this tissue fragment the architectural 
arrangement is beginning to distort, with mild pleomorphism and 
hyperchromasia of the nuclei. Also a mild increase of the nucleo/ 
cytoplasmic ratio is present. Papanicolaou stain, X 1400. 
Fig. 6. Moderate dysplasia. In contrast with fig. 5 there is more 
pleomorphism and increase of the nucleo/cytoplasmic ratio. 
Papanicolaou stain, X 1400. 
Ill 
7. Severe dysplasia. In contrast with figs 5 and 6 there is severe 
pleomorphism and a marked increase of the nucleo/cytoplasmic ratio. 
Papanicolaou stain, X 1400. 
"Hi. 
Well differentiated keratinizing squamous cell cancer. Tadpole cell 
with pleomorphic hyperchromatic nucleus. Note the keratin fibrils in 
the cytoplasm. Papanicolaou stain, X 700. 
• 
Fig. 9. Well differentiated keratinizing squamous cell cancer. Fibercells 
with pleomorphic hyperchromatic nuclei. Keratin masses (squamous 
ghosts) are also present. Papanicolaou stain, X 880. 
Fig· 1Q· Well differentiated keratinizing squamous cell cancer. Malignant 
keratin pearl. Without plemorphism in a keratin pearl, a diagnosis 
of squamous cell cancer should not be made. Papanicolaou stain X 
1400. ' 
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Fig. 11. Well differentiated keratinizing sguamous cell cancer. Tumor 
diathesis. Degenerated tumorcells lying in a background of sguamous 
ghosts, granular debris and polymorphonuclear leucocytes. 
Papanicolaou stain, X 1400. 
: • • • • • 
• 
Fig. 12. Non keratinizing sguamous cell cancer. Note the accentuation of the 
cytoplasmic membrane by which the tumor can be identified as a 
sguamous cell cancer. Papanicolaou stain, X 1400. 
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Fig. 13. Small cell carcinoma. Loose cluster of small malignant cells. Note 
variation in size, irregular nuclear outline and moulding of the 
nuclei. Papanicolaou stain, X 1400. 
^ 
Fig. 14. Small cell carcinoma. Cluster of small cell carcinomacells. Note the 
irregularity of the chromatin, with small nucleoli. Papanicolaou 
stain, X 1400. 
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Fig. 15. Acinar adenocarcinoma. Syncytial arrangement of tumorcells with ill 
defined cell borders and loss of polarity of individual nuclei. 
Prominent nucleoli and irregular clumping of the chromatin are 
present. Papanicolaou stain, X 1400. 
Fig. 16. Papillary adenocarcinoma. In contrast with terminal bronchiolo-
alveolar cell carcinoma (fig. 17) there is more hyperchromasia of 
the nuclei with less symmetry. Papanicolaou stain, X 880. 
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Fig. 17. Terminal bronchiole-alveolar cell carcinoma. Note te excellent 
preservation of tumorcell morphology and fuzzy cell borders, giving 
the appearance of cilia. Papanicolaou stain, X 880. 
Fig. 18. Large cell carcinoma. Tumorcells with very pleomorphic nuclei with 
irregular chromatin pattern and prominent nucleoli. Cell borders are 
indistinct. Misclessification as poorly differentiated adeno-
carcinoma may occur when tumorcells cluster. When tumorcells appear 
in broad sheets this may be suggestive of a poorly differentiated 
squamous cell carcinoma. Papanicolaou stain, X 1400. 
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Fig. 19. Giant cell carcinoma. Pleomorphic multinucleated tumorcells are 
present between tumorcell groups as depicted in fig. 18. 
Papanicolaou stain, X 1400. 
Fig. 20. Carcinoid tumor. Cells are arranged in a loose cluster. Note the 
uniformity, the granularity of the nuclear chromatin and the 
presence of small nucleoli in many cells. Papanicolaou stain, X 
1400. 
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Fig. 21. Fibrosarcoma. The presence of spindle-shaped atypical cells favours 
a diagnosis of sarcoma, but a specific diagnosis is not possible 
from cytologic specimens. Differential diagnosis with carcinosarcoma 
and spindle cell (squamous) carcinoma is a problem too. Papanicolaou 
stain, X 700. 
^ 
Fig. 22. Metastaslc breast carcinoma. Note the resemblance to cells from 
terminal bronchiolo-alveolar cell carcinoma in fig. 17. Clinical 
history and radiographical findings are helpful for a correct 
diagnosis. Papanicolaou stain, X 1400. 
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Fig. 23. Metastatic Grawitz-tumor. Tumorcells with clear cytoplasm with 
prominent borders are arranged in clusters. Differential diagnostic 
problems with primary clear cell carcinoma can occur. Papanicolaou 
stain, X 1400. 
Fig. 24. Metastatic colonic adenocarcinoma. A multilayered cluster of tumor-
cells of elongated columnar type. Papanicolaou stain, X 700. 
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Fig. 25. Hodgkin's disease with secondary infiltration of the lung. Reed-
Sternberg cell. Papanicolaou stain, X 1400. 
Fig. 26. Hamartoma. Cluster of columnar cells with little atypia. Note the 
presence of moulding. Differential diagnosis with small cell cancer 
cells is possible because there is only minimal atypia and lack of a 
coarse chromatin pattern as seen in small cell cancer. Papanicolaou 
stain, X 1400. 
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SUMMARY 
This study concentrated on the determination of the 
diagnostic accuracy of sputum cytology prepared according to the 
Saccomanno method and the influence of patient characteristics on 
the accuracy of sputum diagnosis. 
The analysis of the accuracy of the Saccomanno method for sputum 
cytology revealed several new aspects in sputum cytologic 
diagnosis of lung cancer. 
Overall diagnoses were correct in 85.4% of 1488 patients 
from which satisfactory sputum was available for cytologic 
diagnosis. In 193 (13.0%) of the total patient group a false 
negative diagnosis was given. There were 24 (1.6%) patients with 
false postive diagnoses. In patients with a malignant lung 
process sputum cytology was correct in 228 (54.2%) of the 
patients and false negative in 193 (45.8%) of the patients. 
Five or more sputum specimens of satisfactory quality should 
be diagnosed as negative before a series of sputum examinations 
is be discontinued. 
Thereafter it may be assumed that a given patient does not have a 
primary malignant lung process which can be diagnosed 
cytologically. In primary lungcancer patients there was a sharp 
increase of the probability of finding a correct positive 
cytologic diagnosis on sputum from 0.47 to 0.87 when from one to 
five or more sputum specimens were examined. 
In patients with metastatic lung malignancies there was only a 
weak increase of this probability from 0.35 to 0.38 when one, two 
or more than two sputum samples were examined. 
With the examination of more than five sputum specimens the 
probability rate levels off in both patient groups. 
The Saccomanno sputum method reveals a cytologic typing 
accuracy of 99% and 91% for the clinically most relevant subtypes 
of "non small cell lungcancer" and "small cell lungcancer". The 
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typing accuracy ranged from rather low in large cell carcinomas 
{67%) and adenocarcinomas (73S) to high in small cell cancers 
(91%) and squamous cell cancers (98%) (Chapter 1). 
Chapter 2 deals with the influence of anamnestic and 
clinical characteristics of patients on the probability of a 
correct positive sputum cytologic diagnosis. From 421 patients 
with a malignant lung process and sputum of satisfactory quality, 
patient characteristics were investigated. The presence of bloody 
sputum was highly significantly associated with a correct 
positive sputum diagnosis. In patients with bloody sputum and 
primary lung cancer the proportion of correct positive diagnoses 
was 0.88 when at least three sputum samples were examined. In 
patients with bloody sputum and metastatic lung disease this 
figure was 0.77. 
Furthermore, low FeV^-values (0-50% VC), lung tumors over 24 
mm in diameter and central location of the tumor and squamous 
cell cancer type were significantly related to the diagnostic 
accuracy in patients with primary lung cancer. In patients with 
metastatic lung malignancies the only significant parameter, 
other than bloody sputum, was central location of the tumor. 
From this study a trend to analyze less frequently sputum 
material from patients with chronic lung complaints and/or low 
Vital Capacity values became evident. This resulted in a 
relatively high false negative rate in these patients since 
sputum series were curtailed too early, thus reducing the 
probability of a correct positive sputum diagnosis. 
The relationship between the cellular composition of sputum 
and the diagnostic outcome of sputum cytology in 410 patients 
with primary or metastatic malignant lung processes, is described 
in Chapter 3. 
In patients with primary lung cancer, sputum samples with 
correct positive diagnoses contained significantly more cells 
from the deeper airways, such as alveolar macrophages and 
bronchial columnar cells, than sputum specimens with a false 
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negative diagnosis. 
In sputum samples of patients with metastatic lung 
malignancies there were no significant differences in cellular 
composition between specimens with correct positive and false 
negative diagnoses. The mere presence of alveolar macrophages can 
not serve as an indicator for good sputum because false negative 
sputum specimens also contained alveolar macrophages, though in 
lower numbers. Good quality sputum with the highest chance for a 
correct positive diagnosis should contain a relatively high 
proportion of alveolar macrophages, bronchial columnar cells and 
dysplastic cells. 
Furthermore patient characteristics were analysed which 
showed an influence on the composition of sputum. Squamous 
metaplastic cells were found in significantly higher numbers in 
patients over 60 years of age, in patients with a low Vital 
Capacity and in patients with a low FeVi value. The number of 
alveolar macrophages was significantly higher in patients with 
right sided lung tumors, compared to patients with malignancies 
located in the left lung. Tumor location in the left lung is more 
likely to impede the air passage, which is understandable from 
the anatomy of the trachea and main bronchi. 
Tumor location in the upper lobes is also associated with a 
higher number of macrophages, apparently because these tumors 
block the air passage less completely than tumors in the middle 
or lower lobes. 
Tumors with a peripheral (ve central) location were 
associated with higher number of alveolar macrophages, bronchial 
columnar cells and squamous metaplastic cells in sputum. 
The number of tumor cells was significantly higher in patients 
with centrally located tumors, in patients with tumors over 50 mm 
in diameter, in patients producing bloody sputum and in patients 
with squamous cell cancer. 
In Chapter 4 the influence of bronchoscopy was evaluated on 
the quality of sputum and on the proportion of correct positive 
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sputum diagnoses. This analysis was done in 146 patients with 
primary lung cancer and 21 patients with metastatic lung 
malignancies. The quality of prebronchoscopic sputum was 
significantly better than of postbronchoscopic sputum. The 
percentages of correct positive diagnoses in pre- and 
postbronchoscopy sputum specimens did not differ significantly. 
Only in patients with low FeVj values (0-508 of the Vital 
Capacity) and in patients without a history of previous sputum 
production the results of postbronchoscopy sputum were found to 
be better. In patients with bloody sputum production the results 
of prebronchoscopy sputum proved to be significantly better. 
In Chapter 5 the diagnostic significance of severe 
dysplastic cells in sputum cytology is discussed. In 25 of 46 
patients (54%) with sputum diagnoses consistent with severe 
dysplasia at follow up no malignant lung processes were 
diagnosed. 
In the remaining 21 patients (46%) at follow up of sputum 
diagnoses consistent with severe dysplasia, a malignant process 
became evident. In patients with severe dyspnoea a significantly 
higher number of patients with sputum diagnoses of severe 
dysplasia at follow-up were found to have no pulmonary 
malignancy. 
A significantly higher number of patients with sputum 
diagnoses of severe dysplasia who had two or more characteristics 
indicating "previous pulmonary disease" together with chronic 
cough complaints, did not have a malignant process of the lung. 
Consequently in patients with sputum diagnoses consistent 
with severe dysplasia the absence of these characteristics of 
"chronic pulmonary disease" should be considered a warning signal 
for an underlying malignant tumor. Therefore in these patients 
at follow up examinations extra attention should be given 
towards confirmation of a lung malignancy. 
Chapter 6 deals with the cytopathology of sputum prepared 
with the Saccomanno method. 
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Special attention was given to differential diagnostic problems 
as occur in daily practice in the diagnostic process of benign, 
premalignant and malignant lungprocesses. Characteristic 
cytologic features of lung tumor types classified according to 
the WHO-classification are described. 
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SAMENVATTING 
Dit onderzoek concentreerde zich op het vaststellen van de 
diagnostische accuratesse van sputum cytologie, bewerkt volgens 
de methode van Saccomanno, en van de invloed van patiënt-kenmer-
ken op de betrouwbaarheid van de sputum diagnose. 
De analyse van de accuratesse van de Saccomanno methode voor spu-
tum cytologie leverde verscheidene nieuwe gezichtspunten op in de 
diagnostiek van longkanker met behulp van sputum cytologie. 
In de totaalgroep van 1488 patiënten van wie kwalitatief 
voldoende sputum beschikbaar was voor cytologisch onderzoek was 
de diagnose correct in 85.4%. Bij 193 (13.0%) patiënten was de 
diagnose fout-negatief, en bij 24 (1.6%) patiënten fout-positief. 
Van de groep patiënten met een maligne proces in de long was 
de diagnose correct in 228 (54.2%) patiënten en fout negatief in 
193 (45.8%) patiënten. 
Vijf of meer kwalitatief voldoende spute zouden als negatief 
moeten worden beoordeeld, voordat een serie sputum inzendingen 
mag worden beëindigd. 
In dat geval mag worden aangenomen, dat de betreffende patiënt 
geen cytologisch aantoonbare primaire long maligniteit heeft. 
Wanneer één tot vijf sputa werden onderzocht was er een sterke 
toename van de kans op een correct positieve cytologlsche sputum 
diagnose in patiënten met een primaire maligne long tumor. De 
kans steeg dan van 0.47 naar 0.B7. 
Bij patiënten met een metastatische long maligniteit nam 
deze kans slechts in geringe mate toe, t.w. van 0.35 naar 0.38 
als een, twee of meer dan twee sputa werden onderzocht. Wanneer 
meer dan vijf sputa werden onderzocht nam de kans op een correct 
positieve diagnose niet verder toe in beide groepen van patiën-
ten . 
Met de Saccomanno methode voor sputum kan bij de cytologl-
sche typering van de klinisch meest belangrijke subtypen "niet 
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kleincellig anaplastisch longcercinoom" en "kleincellig anaplas-
tisch longcarcinoom" een accuratesse van 99% respectievelijk 91S 
worden bereikt. 
De accuratesse van de typering varieerde van vrij laag in geval 
van grootcellig anaplastische carcinomen (67S) en adenocarcinomen 
(73%) tot hoog in kleincellig anaplastische carcinomen (91S) en 
plaveiselcelcarcinomen (98%). (Hoofdstuk 1). 
Hoofstuk 2 behandelde de invloed van anamnestische en klini-
sche kenmerken van patiënten op de kans op het stellen van een 
correct positieve cytologische diagnose op sputum. 
Van 421 patiënten met een maligne longproces en kwalitatief 
voldoende sputum werden patiënt-kenmerken onderzocht. De aanwe-
zigheid van bloederig sputum liet een zeer significante samenhang 
zien met een correct positieve diagnose. 
Bij patiënten met bloederig sputum en een primaire long 
maligniteit was de kans op een correct positieve diagnose 0.88, 
als tenminste drie sputa werden onderzocht. Bij patiënten met 
bloederig sputum en een metastatisch maligne long proces was de 
kans 0.77. 
Voorts waren er significante relaties met de diagnostische 
accuratesse bij patiënten met een primaire long maligniteit en 
lage FeVi-waarden (0-50% VC), long tumoren van meer dan 24mm in 
doorsnede, een centrale ligging van de tumor en tumoren van het 
type plaveiselcelcarcinoom. Bij patiënten met een metastatisch 
longproces was behalve bloederig sputum, centrale ligging van de 
tumor de enige significante parameter. 
Dit onderzoek maakte bovendien duidelijk dat de neiging 
bestaat om minder vaak sputum in te zenden van patiënten met 
chronische longklachten en/of lage waarden van Vitale Capaciteit. 
Het resultaat hiervan is, dat bij dit type patiënten een relatief 
hoog aantal fout negatieve diagnosen voorkomt, daar de serie van 
sputum inzendingen te vroeg wordt afgebroken. De kans op het 
stellen van een correct positieve sputum diagnose wordt hierdoor 
verminderd. 
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Het verband tussen de celsamenstelling van sputum en de 
diagnostische opbrengst van sputum cytologie in 410 patiënten met 
primaire of metastatische maligne longprocessen is weergegeven 
in Hoofdstuk 3. 
Bij patiënten met een primaire long maligniteit bevatten 
sputum-monsters met een correct positieve diagnose signficant 
meer cellen afkomstig van de lagere luchtwegen zoals alvéolaire 
macrofagen en bronchiale cylindrische epitheelcellen dan sputum-
monsters met een fout negatieve diagnose. Bij patiënten met een 
metastatische long maligniteit waren er geen significante ver-
schillen wat betreft celsamenstelling van de sputum-monsters met 
correct positieve en fout-negatieve diagnosen. 
De aanwezigheid van alvéolaire macrofagen als enige kwali-
teitsparameter is geen goede garantie voor goed sputum, daar 
fout-negatieve sputa als regel ook alvéolaire macrofagen bevat-
ten, zij het in mindere aantallen. Sputum van goede kwaliteit met 
de grootste kans op een correct positieve diagnose zou een rela-
tief hoog percentage van alvéolaire macrofagen, bronchiale cylin-
drische epitheelcellen en dysplastische cellen moeten bevatten. 
Ook werd onderzocht welke patiënt-kenmerken van invloed zijn 
op de samenstelling van sputum. Squameus metaplastische cellen 
werden in significant hogere aantallen in sputum van patiënten 
ouder dan 60 jaar, van patiënten met een lage Vitale Capaciteit 
en van patiënten met een lage FeV^-wearde aangetroffen. 
Het aantal alvéolaire macrofagen was significant hoger in 
het sputum van patiënten met een tumor gelokaliseerd in de rech-
ter long, dan bij patiënten met een maligne proces in de linker 
long. 
Tumorlokalisatie in de linker long zal eerder de luchtpassage 
belemmeren, hetgeen te begrijpen valt uit de anatomie van de tra-
chea en de hoofdbronchiën. 
Tumorlokalisatie in de bovenkwabben liet eveneens een hoger 
aantal alvéolaire macrofagen zien, blijkbaar omdat door deze pro-
ceseen de luchtpassage minder volledig wordt afgesloten dan bij 
tumoren in de midden of onderkwabben het geval is. 
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Bij tumoren met een perifere ligging kwamen in vergelijking 
met centraal gelegen tumoren meer alvéolaire macrofagen, bronchi-
ale cylindrische cellen en squameus metaplastische cellen in het 
sputum voor. Het aantal tumorcellen was significant hoger bij 
patiënten met een centraal gelegen tumor, bij patiënten met tumo-
ren van meer dan 50mm in doorsnede, bij patiënten die bloederig 
sputum opgaven en ook bij patiënten met plaveiselcelcarcinomen. 
In Hoofdstuk 4 werd de invloed van bronchoscopisch onder-
zoek geëvalueerd op de kwaliteit van het sputum en op het percen-
tage correct positieve sputum-diagnosen. Bij 146 patiënten met 
een primair maligne longproces en 21 patiënten met een metasta-
tisch maligne longproces werd deze analyse uitgevoerd. De kwali-
teit van het sputum vóór bronchoscopie was significant beter dan 
van sputum na bronchoscopie. 
Het percentage correct positieve diagnosen verschilde niet 
significant voor en na bronchoscopie. Slechts bij patiënten met 
lage FeV^-waarden (0-50% van de Vitale Capaciteit) en bij patiën-
ten zonder voorgeschiedenis van sputumproduktie waren de resulta-
ten van het sputum onderzoek na bronchoscopie beter. 
In Hoofdstuk 5 werd de diagnostische betekenis van het voor-
komen van ernstig dysplastische cellen in sputum nagegaan. Bij 25 
van de 46 patiënten (54%) bij wie ernstig dysplastische cellen in 
het sputum waren aangetroffen werd bij follow-up geen maligne 
longproces gevonden. 
Bij de resterende 21 patiënten (46%) kwam bij follow up van 
de sputum diagnose "ernstige dysplasie" een maligne proces aan 
het licht. 
Een relatief groot aantal patiënten met een sputum diagnose 
"ernstige dysplasie" én twee of meer patiëntkenmerken wijzend op 
"voorafgaande longziekten" of chronische longklachten bleek geen 
maligne longproces te hebben. 
Omgekeerd zou afwezigheid van dergelijke patiënt-kenmerken 
van chronische longziekten bij patiënten met ernstige dysplasie 
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in het sputum een waarschuwingsteken moeten zijn voor een hier-
achter verborgen maligne proces. Daarom zou in deze patiënten de 
follow-up moeten worden toegespitst op bevestiging of uitsluiting 
van een kwaadaardig proces in de long. 
In Hoofdstuk 6 zijn cytopathologische kenmerken van ver-
schillende longprocessen in sputum bewerkt volgens de methode van 
Saccomanno beschreven. 
Speciale aandacht werd hierbij gegeven aan differentieel 
diagnostische problemen, zoals deze in de dagelijkse praktijk 
voorkomen bij de diagnostiek van goedaardige, premaligne en 
kwaadaardige longprocessen. De cytologische criteria van long-
tumoren, ingedeeeld volgens de WHO-classificatie, werden gegeven. 
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STELLINGEN 
1. De sensitiviteit van sputum cytologische diagnostiek kan 
niet gegeven worden als een enkelvoudig percentage korrekt 
positief diagnostiseerde patiënten, maar dient gespecifi-
ceerd te worden naar het aantal onderzochte sputum monsters 
per patiënt. 
(dit proefschrift). 
2. Vijf of meer kwalitatief voldoende sputa zou 
moeten worden beoordeeld, voordat een serie 
gen bij het onderzoek naar een kwaadaardige 
long mag worden beëindigd. 
(dit proefschrift). 
3. In tegenstelling tot hetgeen algemeen wordt aangenomen vormt 
de aanwezigheid van alvéolaire macrofagen geen voldoende 
garantie voor een goede kwaliteit van het sputum. 
(dit proefschrift). 
4. Bij revisie van histologische preparaten van komplete of 
partiële mola hydatidosa blijkt in 16% van de gevallen de 
afwijking te zijn overgewaardeerd. Het is daarom aan te 
bevelen de diagnose te laten bevestigen door op dit gebied 
ervaren patholoog-anatomen. 
(H.R. Franke, E.K.J. Risse, P. Kenemans, G.P. Vooijs, 3.G. 
Stolk, Epidemiologie Features of Hydatidiform Mole in the 
Netherlands, Obstetrics & Gynecology, 1983, 62: 613-616). 
5. Bij bevolkingsonderzoek naar borstkanker heeft overdiagnos-
tiek van goedaardige afwijkingen aanzienlijk meer schadelij-
ke gevolgen dan onderdiagnostiek van een enkel kwaadaardig 
proces. Daarom dient bij de nascholing van patholoog-anato-
men in de diagnostiek van bij screening vastgestelde afwij-
kingen niet zozeer extra aandacht te worden gegeven aan de 
problematiek van kwaadaardige tumoren, alswel aan het goed-
aardige karakter van talrijke voor maligniteit verdachte 
proliferatieve veranderingen. 
(R. Holland, 19Θ6). 
den als negatief 
sputum inzendin-
afwijking van de 
6. De atypische cellen in baarmoederhalsuitst rijken van vrou-
wen, die een "spiraaltje" als anticonceptiemiddel gebrui-
ken, zullen als regel verdwijnen na verwijdering van het 
"spiraaltje". Bij deze vrouwen dient dan ook in eerste 
instantie een conservatieve follow-up te worden gevolgd. 
(E.K.3. Risse, R.J.C. Beerthuizen, G.P. Vooijs, Cytologie 
and histologie findings in women uaing an I.U.D., Obstetrics 
4 Gynecology, 1981, 58: 569-573). 
7. Het niet progressieve karakter van de meerderheid van de 
premaligne afwijkingen van de cervix uteri rechtvaardigt ala 
regel een beperking van het vervolgonderzoek tot cytologi-
sche en kolposcopische contrôle. 
8. Bij de verslaglegging van een cytologisch onderzoek van de 
baarmoederhals dient een advies voor de herhaling van het 
cytologische onderzoek of het uitvoeren van histologisch 
onderzoek deel uit te maken van de conclusie. 
9. Het gebruik van de cytobrush voor afname van baarmoederhels-
uitstrijken dient alleen op indicatie te geschieden. 
10. Patholoog-anatomen dienen ervoor te waken dat mor fometrisch 
onderzoek van histo-/cytologische preparaten de zorgvuldig-
heid van de licht microscopische beoordeling daarvan niet in 
gevaar brengt. 
11. Bezuinigingen in de gezondheidszorg leveren geen enkel pro-
bleem op, zolang met de kwaliteit van die gezondheidszorg 
geen rekening wordt gehouden. 
12. Het hebben van één Jack-Russell terriër is leuk, het hebben 
van meerdere Jack-Russell terriërs is adembenemend. 
Nijmegen, 19 februari 1987 E.K.J. Risse 
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